Perceptive Advisors Llc - Insider Trading Tracker

एक्रिवोन थेरेप्यूटिक्स, इंक.

US ˙ NasdaqGM ˙ US0048901096

परिचय

यह पृष्ठ Perceptive Advisors Llc के ज्ञात इनसाइडर व्यापार इतिहास का व्यापक विश्लेषण प्रदान करता है। इनसाइडर किसी कंपनी के अधिकारी, निदेशक या महत्वपूर्ण निवेशक होते हैं। इनसाइडर के लिए विशिष्ट, गैर-सार्वजनिक जानकारी के आधार पर अपनी कंपनियों में व्यापार करना गैरकानूनी है। इसका मतलब यह नहीं है कि उनके लिए अपनी कंपनियों में कोई भी व्यापार करना गैरकानूनी है। हालाँकि, उन्हें फॉर्म 4 के माध्यम से SEC को सभी ट्रेड्स की रिपोर्ट करनी होगी। इन प्रतिबंधों के बावजूद, अकादमिक शोध से पता चलता है कि इनसाइडर - सामान्य तौर पर - अपनी कंपनियों में बाजार से बेहतर प्रदर्शन करते हैं।

औसत व्यापार लाभप्रदता

औसत ट्रेड लाभप्रदता पिछले तीन वर्षों में इनसाइडर द्वारा की गई सभी खुले बाजार खरीद का औसत रिटर्न है। इसकी गणना करने के लिए, हम 10b5-1 ट्रेडिंग योजना के हिस्से के रूप में चिह्नित सभी ट्रेडों को छोड़कर, इनसाइडर द्वारा की गई प्रत्येक खुले बाजार, अनियोजित खरीदारी की जांच करते हैं। फिर हम 3, 6 और 12 महीनों में उन ट्रेडों के औसत प्रदर्शन की गणना करते हैं, प्रत्येक ट्रेड के लिए अंतिम प्रदर्शन मीट्रिक तैयार करने के लिए उनमें से प्रत्येक अवधि का औसत निकालते हैं। अंत में, हम इनसाइडर के लिए प्रदर्शन मीट्रिक की गणना करने के लिए सभी प्रदर्शन मीट्रिक का औसत निकालते हैं। इस सूची में केवल उन इनसाइडर को शामिल किया गया है जिन्होंने पिछले दो वर्षों में कम से कम तीन ट्रेड किए हैं।

यदि इस इनसाइडर ट्रेड की लाभप्रदता "N/A" है, तो इनसाइडर ने या तो पिछले तीन वर्षों में कोई खुले बाजार में खरीदारी नहीं की है, या उनके द्वारा किए गए व्यापार एक विश्वसनीय प्रदर्शन मीट्रिक की गणना करने के लिए बहुत हाल के हैं।

अपडेट फ्रीक्वेंसी: दैनिक

सर्वाधिक लाभदायक इनसाइडर व्यापारियों की सूची देखें।

उच्चतम रैंकिंग वाले इनसाइडर देखें

रिपोर्ट की गई इनसाइडर स्थिति वाली कंपनियाँ

SEC फाइलिंग से संकेत मिलता है कि Perceptive Advisors Llc ने निम्नलिखित कंपनियों में होल्डिंग्स या ट्रेड्स की सूचना दी है:

प्रतिभूति	टाइटल	नवीनतम रिपोर्ट की गई होल्डिंग्स
US:OBIO / Orchestra BioMed Holdings, Inc.	10% Owner	5,292,556
US:ACRV / Acrivon Therapeutics, Inc.	10% Owner	3,104,139
US:ALDX / Aldeyra Therapeutics, Inc.	10% Owner	5,875,851
US:SLDB / Solid Biosciences Inc.	Director, 10% Owner	11,833,539
	Director, 10% Owner	9,675,684
US:MGTX / MeiraGTx Holdings plc	Director, 10% Owner	12,531,103
US:CERE / Cerevel Therapeutics Holdings, Inc.	Director	0
US:LIAN / LianBio - Depositary Receipt (Common Stock)	Director, 10% Owner	17,082
US:ATXS / Astria Therapeutics, Inc.	Director	4,873,721
US:ATHA / Athira Pharma, Inc.	Director, 10% Owner	5,402,964
US:VRCA / Verrica Pharmaceuticals Inc.	10% Owner	7,099,182
US:CRGX / CARGO Therapeutics, Inc.		333,333
US:SLNO / Soleno Therapeutics, Inc.	10% Owner	3,074,542
US:LYRA / Lyra Therapeutics, Inc.	Director, 10% Owner	11,469,117
US:CEMI / Chembio Diagnostics Inc.		0
US:VBIV / VBI Vaccines Inc.	10% Owner	41,440,729
US:QTNT / Quotient Ltd	10% Owner	7,945,211
US:ALBO / Albireo Pharma Inc	10% Owner	1,939,723
US:CRNX / Crinetics Pharmaceuticals, Inc.	10% Owner	5,321,032
US:NAUT / Nautilus Biotechnology, Inc.	Director	9,111,151
US:AGRX / Agile Therapeutics, Inc.	10% Owner	2,687,280
US:ISO / IsoPlexis Corp	10% Owner	0
	10% Owner	2,487,019
US:ADMA / ADMA Biologics, Inc.	10% Owner	13,262,375
US:LPTX / Leap Therapeutics, Inc.	10% Owner	3,508,771
US:LABP / Landos Biopharma, Inc.	Director, 10% Owner	25,291
US:VYNE / VYNE Therapeutics Inc.	10% Owner	4,935,057
US:RXDX / Prometheus Biosciences Inc	10% Owner	0
US:SCYX / SCYNEXIS, Inc.	10% Owner	2,400,000
US:MOTS / Motus GI Holdings, Inc.	10% Owner	2,660,542
US:ATNX / Athenex Inc	10% Owner	13,532,467
US:KDMN / Kadmon Holdings Inc		14,636,334
US:DOVA / Dova Pharmaceuticals, Inc.	10% Owner	0
US:FOMX / Foamix Pharmaceuticals Ltd.	10% Owner	22,407,762
US:LJPC / La Jolla Pharmaceutical Co.	10% Owner	2,253,376
US:CORI / Corium International, Inc.	10% Owner	2,724,686
US:FOLD / Amicus Therapeutics, Inc.	10% Owner	20,724,424
US:ZGNX / Zogenix Inc	10% Owner	4,070,357
US:GBT / Global Blood Therapeutics Inc.	10% Owner	4,889,066
US:VSAR / Versartis, Inc..	10% Owner	2,099,563
US:ACRX / Talphera, Inc.	10% Owner	4,533,728
CA: / VBI Vaccines Inc	10% Owner	2,068,824
US:AEGR / Aegerion Pharmaceuticals, Inc.	10% Owner	2,823,426
	10% Owner	22,000
US:XTLB / XTL Biopharmaceuticals Ltd. - Depositary Receipt (Common Stock)	10% Owner	20,580,260
US:BPA /	10% Owner	209,100
US:AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF	10% Owner	2,700,000

चार्ट को कैसे समझे

निम्नलिखित चार्ट Perceptive Advisors Llc द्वारा किए गए प्रत्येक खुले-बाज़ार, गैर-योजनाबद्ध व्यापार के बाद प्रतिभूतियों के स्टॉक प्रदर्शन को दर्शाते हैं। गैर-योजनाबद्ध व्यापार वे व्यापार हैं जो 10b5-1 ट्रेडिंग योजना के हिस्से के रूप में नहीं किए गए थे। स्टॉक प्रदर्शन को शेयर मूल्य में संचयी प्रतिशत परिवर्तन के रूप में चार्ट किया गया है। उदाहरण के लिए, यदि कोई इनसाइडर व्यापार 1 जनवरी, 2019 को किया गया था, तो चार्ट आज तक प्रतिभूति में दैनिक प्रतिशत परिवर्तन दिखाएगा। यदि इस दौरान शेयर की कीमत $10 से $15 तक जाती है, तो शेयर की कीमत में संचयी प्रतिशत परिवर्तन 50% होगा। $10 से $20 तक की कीमत में परिवर्तन 100% होगा, और $10 से $5 की कीमत में परिवर्तन -50% होगा।

अंततः, हम यह निर्धारित करने का प्रयास कर रहे हैं कि इनसाइडर के व्यापार शेयर की कीमत में अतिरिक्त रिटर्न (सकारात्मक या नकारात्मक) से कितनी निकटता से संबंधित हैं, यह देखने के लिए कि क्या इनसाइडर, इनसाइडर जानकारी से लाभ के लिए अपने व्यापार का समय निर्धारित कर रहे हैं। उस स्थिति पर विचार करें जहां कोई इनसाइडर ऐसा कर रहा था। इस स्थिति में, हम या तो (a) खरीदारी के बाद सकारात्मक रिटर्न, या (a) बिक्री के बाद नकारात्मक रिटर्न की उम्मीद करेंगे। (a) के मामले में, खरीद चार्ट ऊपर की ओर झुके हुए वक्रों की एक श्रृंखला दिखाएगा, जो प्रत्येक खरीद लेनदेन के बाद सकारात्मक रिटर्न का संकेत देगा। (a) के मामले में, बिक्री चार्ट नीचे की ओर झुके हुए वक्रों की एक श्रृंखला दिखाएगा, जो प्रत्येक बिक्री लेनदेन के बाद नकारात्मक रिटर्न का संकेत देगा।

हालाँकि, केवल यह निष्कर्ष निकालने के लिए पर्याप्त नहीं है। यदि, उदाहरण के लिए, कंपनी का शेयर मूल्य कई वर्षों से गैर-चक्रीय चढ़ाई में था, तो हम उम्मीद करेंगे कि खरीद के बाद के सभी प्लॉट ऊपर की ओर झुके हुए होंगे। इसी तरह, कई वर्षों में गैर-चक्रीय गिरावट के परिणामस्वरूप व्यापार के बाद के प्लॉट नीचे की ओर झुकेंगे। इनमें से कोई भी चार्ट इनसाइडर व्यापार गतिविधि का सुझाव नहीं देगा।

सबसे मजबूत संकेतक वह स्थिति होगी जहां शेयर की कीमत बेहद चक्रीय थी, और खरीद चार्ट में सकारात्मक संकेत और बिक्री चार्ट पर नकारात्मक प्लॉट दोनों थे। यह स्थिति एक इनसाइडर के लिए अत्यधिक संकेत देने वाली होगी जो अपने वित्तीय लाभ के लिए ट्रेड्स का समय निर्धारित कर रहा था।

इनसाइडर खरीदारी ACRV / Acrivon Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

इस अनुभाग में, हम ACRV / Acrivon Therapeutics, Inc. में की गई प्रत्येक अनियोजित, खुले बाज़ार की इनसाइडर खरीदारी की लाभप्रदता का विश्लेषण करते हैं। यह विश्लेषण यह समझने में मदद करता है कि क्या इनसाइडर लगातार असामान्य रिटर्न उत्पन्न करता है, और यह अनुसरण करने लायक है। यह विश्लेषण प्रत्येक व्यापार के बाद एक वर्ष के लिए है, और परिणाम सैद्धांतिक हैं।

निम्न तालिका सबसे हालिया खुले बाज़ार की खरीदारी को दर्शाती है जो स्वचालित ट्रेडिंग योजना का हिस्सा नहीं थी।

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2024-04-11	ACRV	PERCEPTIVE ADVISORS LLC	2,353,000	8.5000	2,353,000	8.5000	20,000,500	7	10.5400	4,800,120	24.00

समायोजित कीमत विभाजित-समायोजित कीमत है। समायोजित शेयर विभाजित-समायोजित शेयर हैं।

ACRV / Acrivon Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री ACRV / Acrivon Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

इस अनुभाग में, हम ACRV / Acrivon Therapeutics, Inc. में की गई प्रत्येक अनियोजित, खुले बाज़ार की इनसाइडर बिक्री के अल्पकालिक नुकसान से बचने का विश्लेषण करते हैं। हानि से बचने का एक सुसंगत पैटर्न यह सुझाव दे सकता है कि भविष्य में बिक्री लेनदेन कीमत में गिरावट की भविष्यवाणी कर सकते हैं। यह विश्लेषण प्रत्येक व्यापार के बाद एक वर्ष के लिए है, और परिणाम सैद्धांतिक हैं।

निम्न तालिका सबसे हालिया खुले बाज़ार की बिक्री को दर्शाती है जो स्वचालित ट्रेडिंग योजना का हिस्सा नहीं थी।

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2025-05-01	ACRV	PERCEPTIVE ADVISORS LLC	298,886	1.3400	298,886	1.3400	400,507	29	1.0500	-86,677	-21.64
2025-04-30	ACRV	PERCEPTIVE ADVISORS LLC	437,881	1.4100	437,881	1.4100	617,412
2025-04-29	ACRV	PERCEPTIVE ADVISORS LLC	250,000	1.4100	250,000	1.4100	352,500
2025-04-28	ACRV	PERCEPTIVE ADVISORS LLC	215,283	1.5600	215,283	1.5600	335,841
2025-04-25	ACRV	PERCEPTIVE ADVISORS LLC	1,054,669	1.9500	1,054,669	1.9500	2,056,605

इनसाइडर खरीदारी ADMA / ADMA Biologics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2020-03-19	ADMA	PERCEPTIVE ADVISORS LLC	500,000	2.1000	500,000	2.1000	1,050,000	133	3.7400	820,000	78.10
2020-02-11	ADMA	PERCEPTIVE ADVISORS LLC	4,563,700	3.5000	4,563,700	3.5000	15,972,950
2019-05-21	ADMA	PERCEPTIVE ADVISORS LLC	4,000,000	4.0000	4,000,000	4.0000	16,000,000

ADMA / ADMA Biologics, Inc. Insider Trades

इनसाइडर बिक्री ADMA / ADMA Biologics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2021-09-30	ADMA	PERCEPTIVE ADVISORS LLC	137,495	1.1200	137,495	1.1200	153,994	11	1.09	-4,124	-2.68
2021-09-29	ADMA	PERCEPTIVE ADVISORS LLC	82,505	1.1600	82,505	1.1600	95,706
2021-09-28	ADMA	PERCEPTIVE ADVISORS LLC	40,603	1.2200	40,603	1.2200	49,536
2021-09-27	ADMA	PERCEPTIVE ADVISORS LLC	250,000	1.2300	250,000	1.2300	307,500
2021-09-24	ADMA	PERCEPTIVE ADVISORS LLC	250,000	1.2600	250,000	1.2600	315,000
2021-09-23	ADMA	PERCEPTIVE ADVISORS LLC	780,000	1.2700	780,000	1.2700	990,600
2021-08-19	ADMA	PERCEPTIVE ADVISORS LLC	350,352	1.2400	350,352	1.2400	434,436
2021-08-18	ADMA	PERCEPTIVE ADVISORS LLC	552,380	1.2900	552,380	1.2900	712,570
2021-08-17	ADMA	PERCEPTIVE ADVISORS LLC	879,092	1.3500	879,092	1.3500	1,186,774

इनसाइडर खरीदारी AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF Insider Trades

इनसाइडर बिक्री AIS / Tidal Trust III - VistaShares Artificial Intelligence Supercycle ETF - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी ALDX / Aldeyra Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2024-04-05	ALDX	PERCEPTIVE ADVISORS LLC	37,712	4.7400	37,712	4.7400	178,755	341	6.9800	84,476	47.26
2024-04-04	ALDX	PERCEPTIVE ADVISORS LLC	140,281	4.6700	140,281	4.6700	655,112
2024-04-03	ALDX	PERCEPTIVE ADVISORS LLC	309,847	4.0900	309,847	4.0900	1,267,274
2024-04-02	ALDX	PERCEPTIVE ADVISORS LLC	186,051	3.4400	186,051	3.4400	640,015
2024-04-01	ALDX	PERCEPTIVE ADVISORS LLC	8,374	3.2500	8,374	3.2500	27,216
2022-08-10	ALDX	PERCEPTIVE ADVISORS LLC	15,000	7.8500	15,000	7.8500	117,750
2022-08-09	ALDX	PERCEPTIVE ADVISORS LLC	100,000	7.5000	100,000	7.5000	750,000
2022-08-08	ALDX	PERCEPTIVE ADVISORS LLC	97,000	7.2400	97,000	7.2400	702,280
2022-08-05	ALDX	PERCEPTIVE ADVISORS LLC	141,000	6.9500	141,000	6.9500	979,950
2022-08-04	ALDX	PERCEPTIVE ADVISORS LLC	95,100	6.1700	95,100	6.1700	586,767
2022-08-03	ALDX	PERCEPTIVE ADVISORS LLC	100,000	5.8400	100,000	5.8400	584,000
2022-08-02	ALDX	PERCEPTIVE ADVISORS LLC	412,406	5.5900	412,406	5.5900	2,305,350
2022-08-01	ALDX	PERCEPTIVE ADVISORS LLC	144,185	5.0500	144,185	5.0500	728,134
2022-07-29	ALDX	PERCEPTIVE ADVISORS LLC	222,123	5.0300	222,123	5.0300	1,117,279
2022-07-28	ALDX	PERCEPTIVE ADVISORS LLC	119,392	5.0000	119,392	5.0000	596,960
2021-05-03	ALDX	PERCEPTIVE ADVISORS LLC	1,200,000	12.5000	1,200,000	12.5000	15,000,000
2021-01-19	ALDX	PERCEPTIVE ADVISORS LLC	1,368,421	9.5000	1,368,421	9.5000	13,000,000
2021-01-08	ALDX	PERCEPTIVE ADVISORS LLC	347,332	9.2100	347,332	9.2100	3,198,928
2021-01-08	ALDX	PERCEPTIVE ADVISORS LLC	152,668	10.2100	152,668	10.2100	1,558,740
2021-01-08	ALDX	PERCEPTIVE ADVISORS LLC	50,000	7.6000	50,000	7.6000	380,000
2021-01-07	ALDX	PERCEPTIVE ADVISORS LLC	500,000	8.1300	500,000	8.1300	4,065,000
2020-07-09	ALDX	PERCEPTIVE ADVISORS LLC	3,200,000	4.2500	3,200,000	4.2500	13,600,000
2017-09-19	ALDX	PERCEPTIVE ADVISORS LLC	200,000	7.2500	200,000	7.2500	1,450,000
2017-06-30	ALDX	PERCEPTIVE ADVISORS LLC	296,007	4.6000	296,007	4.6000	1,361,632
2017-02-14	ALDX	PERCEPTIVE ADVISORS LLC	893,025	4.5000	893,025	4.5000	4,018,612
2016-05-26	ALDX	PERCEPTIVE ADVISORS LLC	700,000	5.0000	700,000	5.0000	3,500,000
2015-10-28	ALDX	PERCEPTIVE ADVISORS LLC	45,100	6.5000	45,100	6.5000	293,150
2015-10-26	ALDX	PERCEPTIVE ADVISORS LLC	50,000	6.4630	50,000	6.4630	323,150
2015-10-22	ALDX	PERCEPTIVE ADVISORS LLC	18,020	6.4740	18,020	6.4740	116,661
2015-10-20	ALDX	PERCEPTIVE ADVISORS LLC	14,348	6.2960	14,348	6.2960	90,335
2015-10-20	ALDX	PERCEPTIVE ADVISORS LLC	22,797	6.4420	22,797	6.4420	146,858

ALDX / Aldeyra Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री ALDX / Aldeyra Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2025-04-03	ALDX	PERCEPTIVE ADVISORS LLC	3,400,000	1.4200	3,400,000	1.4200	4,828,000	0	1.4200	0	0.00
2023-10-18	ALDX	PERCEPTIVE ADVISORS LLC	306,499	1.7400	306,499	1.7400	533,308
2023-10-16	ALDX	PERCEPTIVE ADVISORS LLC	2,450,000	1.6000	2,450,000	1.6000	3,920,000

इनसाइडर खरीदारी ANIP / ANI Pharmaceuticals, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम
2004-12-02	BPA	EDELMAN JOSEPH	2,000	3.9800	2,000	3.9800	7,960	730
2004-10-08	BPA	EDELMAN JOSEPH	1,000	9.8652	1,000	9.8652	9,865
2004-10-08	BPA	EDELMAN JOSEPH	14,900	9.8652	14,900	9.8652	146,991
2004-10-07	BPA	EDELMAN JOSEPH	1,000	10.1071	1,000	10.1071	10,107
2004-10-07	BPA	EDELMAN JOSEPH	9,000	10.1071	9,000	10.1071	90,964
2004-10-06	BPA	EDELMAN JOSEPH	1,000	9.9013	1,000	9.9013	9,901
2004-10-06	BPA	EDELMAN JOSEPH	9,000	9.9013	9,000	9.9013	89,112
2004-10-05	BPA	EDELMAN JOSEPH	1,700	9.8998	1,700	9.8998	16,830
2004-10-05	BPA	EDELMAN JOSEPH	15,800	9.8998	15,800	9.8998	156,417
2004-10-04	BPA	EDELMAN JOSEPH	1,400	9.7207	1,400	9.7207	13,609
2004-10-04	BPA	EDELMAN JOSEPH	13,100	9.7207	13,100	9.7207	127,341
2004-10-01	BPA	EDELMAN JOSEPH	2,100	9.5900	2,100	9.5900	20,139
2004-10-01	BPA	EDELMAN JOSEPH	19,400	9.5900	19,400	9.5900	186,046
2004-09-30	BPA	EDELMAN JOSEPH	1,000	8.9645	1,000	8.9645	8,964
2004-09-30	BPA	EDELMAN JOSEPH	9,000	8.9645	9,000	8.9645	80,680
2004-09-14	BPA	EDELMAN JOSEPH	2,400	7.6852	2,400	7.6852	18,444
2004-09-14	BPA	EDELMAN JOSEPH	22,100	7.6852	22,100	7.6852	169,843
2004-09-13	BPA	EDELMAN JOSEPH	2,500	7.1681	2,500	7.1681	17,920
2004-09-13	BPA	EDELMAN JOSEPH	23,400	7.1681	23,400	7.1681	167,734
2004-09-09	BPA	EDELMAN JOSEPH	400	6.8500	400	6.8500	2,740
2004-09-09	BPA	EDELMAN JOSEPH	4,300	6.8500	4,300	6.8500	29,455
2004-08-31	BPA	EDELMAN JOSEPH	9,000	6.8403	9,000	6.8403	61,563
2004-08-30	BPA	EDELMAN JOSEPH	1,000	6.8374	1,000	6.8374	6,837
2004-08-30	BPA	EDELMAN JOSEPH	9,000	6.8374	9,000	6.8374	61,537
2004-08-19	BPA	EDELMAN JOSEPH	6,200	5.8446	6,200	5.8446	36,237
2004-08-19	BPA	EDELMAN JOSEPH	700	5.8446	700	5.8446	4,091
2004-08-18	BPA	EDELMAN JOSEPH	40,500	5.8253	40,500	5.8253	235,925
2004-08-18	BPA	EDELMAN JOSEPH	4,500	5.8253	4,500	5.8253	26,214
2004-08-16	BPA	EDELMAN JOSEPH	200	5.1000	200	5.1000	1,020
2004-08-12	BPA	EDELMAN JOSEPH	2,500	4.7500	2,500	4.7500	11,875
2004-08-11	BPA	EDELMAN JOSEPH	21,300	4.7175	21,300	4.7175	100,483
2004-08-11	BPA	EDELMAN JOSEPH	2,300	4.7175	2,300	4.7175	10,850
2004-07-19	BPA	EDELMAN JOSEPH	25,652	5.6747	25,652	5.6747	145,567
2004-07-19	BPA	EDELMAN JOSEPH	2,800	5.6747	2,800	5.6747	15,889
2004-07-16	BPA	EDELMAN JOSEPH	12,648	5.8877	12,648	5.8877	74,468
2004-07-16	BPA	EDELMAN JOSEPH	1,400	5.8870	1,400	5.8870	8,242
2004-07-15	BPA	EDELMAN JOSEPH	6,750	5.9633	6,750	5.9633	40,252
2004-07-15	BPA	EDELMAN JOSEPH	750	5.9633	750	5.9633	4,472
2004-05-14	BPA	EDELMAN JOSEPH	650,000	6.0000	650,000	6.0000	3,900,000

ANIP / ANI Pharmaceuticals, Inc. Insider Trades

इनसाइडर बिक्री ANIP / ANI Pharmaceuticals, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम
2004-12-03	BPA	EDELMAN JOSEPH	30,000	4.3500	30,000	4.3500	130,500	730
2004-12-03	BPA	EDELMAN JOSEPH	50,000	4.5500	50,000	4.5500	227,500
2004-12-03	BPA	EDELMAN JOSEPH	1,315,000	4.7150	1,315,000	4.7150	6,200,225
2004-12-02	BPA	EDELMAN JOSEPH	28,550	4.4680	28,550	4.4680	127,561
2004-12-02	BPA	EDELMAN JOSEPH	70,900	4.4680	70,900	4.4680	316,781
2004-12-02	BPA	EDELMAN JOSEPH	25,000	4.9000	25,000	4.9000	122,500
2004-12-02	BPA	EDELMAN JOSEPH	2,000	4.4680	2,000	4.4680	8,936
2004-12-02	BPA	EDELMAN JOSEPH	273,550	4.4680	273,550	4.4680	1,222,221
2004-08-16	BPA	EDELMAN JOSEPH	200	5.5000	200	5.5000	1,100
2004-02-03	BPA	EDELMAN JOSEPH	87,400	6.4368	87,400	6.4368	562,576
2004-01-23	BPA	EDELMAN JOSEPH	35,000	5.6200	35,000	5.6200	196,700
2004-01-22	BPA	EDELMAN JOSEPH	100,000	5.6800	100,000	5.6800	568,000
2004-01-21	BPA	EDELMAN JOSEPH	100,000	5.6600	100,000	5.6600	566,000
2004-01-21	BPA	EDELMAN JOSEPH	15,000	5.8400	15,000	5.8400	87,600
2004-01-21	BPA	EDELMAN JOSEPH	5,000	5.6500	5,000	5.6500	28,250

इनसाइडर खरीदारी ATHA / Athira Pharma, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2023-12-29	ATHA	PERCEPTIVE ADVISORS LLC	163,954	2.3800	163,954	2.3800	390,211	69	4.1500	290,199	74.37
2023-12-28	ATHA	PERCEPTIVE ADVISORS LLC	409,598	2.4400	409,598	2.4400	999,419
2023-12-27	ATHA	PERCEPTIVE ADVISORS LLC	32,134	2.2800	32,134	2.2800	73,266
2022-06-30	ATHA	PERCEPTIVE ADVISORS LLC	1,101,362	2.9900	1,101,362	2.9900	3,293,072
2022-06-29	ATHA	PERCEPTIVE ADVISORS LLC	270,000	2.9900	270,000	2.9900	807,300
2021-01-25	ATHA	PERCEPTIVE ADVISORS LLC	311,111	22.5000	311,111	22.5000	6,999,998
2020-09-22	ATHA	PERCEPTIVE ADVISORS LLC	1,058,824	17.0000	1,058,824	17.0000	18,000,008

ATHA / Athira Pharma, Inc. Insider Trades

इनसाइडर बिक्री ATHA / Athira Pharma, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी ATXS / Astria Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2024-02-01	ATXS	PERCEPTIVE ADVISORS LLC	2,481,350	12.0900	2,481,350	12.0900	29,999,522	47	16.6900	11,414,210	38.05
2023-12-21	ATXS	PERCEPTIVE ADVISORS LLC	740,000	6.2000	740,000	6.2000	4,588,000
2023-10-16	ATXS	PERCEPTIVE ADVISORS LLC	614,062	6.5140	614,062	6.5140	4,000,000
2023-10-16	ATXS	PERCEPTIVE ADVISORS LLC	460,546	6.5140	460,546	6.5140	2,999,997
2022-12-19	ATXS	PERCEPTIVE ADVISORS LLC	908,265	11.0100	908,265	11.0100	9,999,998

ATXS / Astria Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री ATXS / Astria Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी CRNX / Crinetics Pharmaceuticals, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2022-04-18	CRNX	PERCEPTIVE ADVISORS LLC	157,515	22.2200	157,515	22.2200	3,499,983	2	23.2200	157,515	4.50
2021-10-25	CRNX	PERCEPTIVE ADVISORS LLC	1,200,000	19.8000	1,200,000	19.8000	23,760,000
2021-04-08	CRNX	PERCEPTIVE ADVISORS LLC	304,136	16.4400	304,136	16.4400	4,999,996
2020-04-17	CRNX	PERCEPTIVE ADVISORS LLC	1,071,428	14.0000	1,071,428	14.0000	14,999,992
2018-07-20	CRNX	PERCEPTIVE ADVISORS LLC	400,000	17.0000	400,000	17.0000	6,800,000
2018-07-20	CRNX	PERCEPTIVE ADVISORS LLC	400,000	17.0000	400,000	17.0000	6,800,000
2018-07-18	CRNX	PERCEPTIVE ADVISORS LLC	307,648	21.3000	307,648	21.3000	6,552,902

CRNX / Crinetics Pharmaceuticals, Inc. Insider Trades

इनसाइडर बिक्री CRNX / Crinetics Pharmaceuticals, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी FOLD / Amicus Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2018-10-03	FOLD	PERCEPTIVE ADVISORS LLC	30,000	12.6900	30,000	12.6900	380,700	184	14.4	51,300	13.48
2018-09-24	FOLD	PERCEPTIVE ADVISORS LLC	20,000	12.4500	20,000	12.4500	249,000
2018-09-21	FOLD	PERCEPTIVE ADVISORS LLC	50,000	12.5300	50,000	12.5300	626,500
2018-09-13	FOLD	PERCEPTIVE ADVISORS LLC	100,000	11.7400	100,000	11.7400	1,174,000
2018-09-12	FOLD	PERCEPTIVE ADVISORS LLC	500,000	12.0030	500,000	12.0030	6,001,500
2018-03-05	FOLD	PERCEPTIVE ADVISORS LLC	335,827	13.5600	335,827	13.5600	4,553,814
2018-03-02	FOLD	PERCEPTIVE ADVISORS LLC	100,000	13.8950	100,000	13.8950	1,389,500
2018-03-01	FOLD	PERCEPTIVE ADVISORS LLC	100,000	13.6900	100,000	13.6900	1,369,000
2017-07-13	FOLD	PERCEPTIVE ADVISORS LLC	1,500,000	12.2500	1,500,000	12.2500	18,375,000
2016-12-30	FOLD	PERCEPTIVE ADVISORS LLC	94,750	4.9610	94,750	4.9610	470,055
2016-12-29	FOLD	PERCEPTIVE ADVISORS LLC	94,750	4.8540	94,750	4.8540	459,916
2016-12-28	FOLD	PERCEPTIVE ADVISORS LLC	47,375	4.9120	47,375	4.9120	232,706
2016-12-23	FOLD	PERCEPTIVE ADVISORS LLC	47,375	4.7170	47,375	4.7170	223,468
2016-12-23	FOLD	PERCEPTIVE ADVISORS LLC	37,900	4.9230	37,900	4.9230	186,582
2016-12-22	FOLD	PERCEPTIVE ADVISORS LLC	189,500	4.5110	189,500	4.5110	854,834
2015-10-07	FOLD	PERCEPTIVE ADVISORS LLC	50,000	6.2700	50,000	6.2700	313,500
2015-10-06	FOLD	PERCEPTIVE ADVISORS LLC	86,000	6.6500	86,000	6.6500	571,900
2015-10-06	FOLD	PERCEPTIVE ADVISORS LLC	86,000	6.4700	86,000	6.4700	556,420
2015-10-06	FOLD	PERCEPTIVE ADVISORS LLC	43,000	6.3400	43,000	6.3400	272,620
2015-10-06	FOLD	PERCEPTIVE ADVISORS LLC	14,000	6.6500	14,000	6.6500	93,100
2015-10-06	FOLD	PERCEPTIVE ADVISORS LLC	14,000	6.4700	14,000	6.4700	90,580
2015-10-06	FOLD	PERCEPTIVE ADVISORS LLC	7,000	6.3400	7,000	6.3400	44,380
2015-10-05	FOLD	PERCEPTIVE ADVISORS LLC	215,000	6.8500	215,000	6.8500	1,472,750
2015-10-05	FOLD	PERCEPTIVE ADVISORS LLC	215,000	6.7600	215,000	6.7600	1,453,400
2015-10-05	FOLD	PERCEPTIVE ADVISORS LLC	35,000	6.8500	35,000	6.8500	239,750
2015-10-05	FOLD	PERCEPTIVE ADVISORS LLC	35,000	6.7600	35,000	6.7600	236,600
2014-11-19	FOLD	PERCEPTIVE ADVISORS LLC	2,100,000	6.5000	2,100,000	6.5000	13,650,000
2014-06-30	FOLD	PERCEPTIVE ADVISORS LLC	3,470,000	3.5000	3,470,000	3.5000	12,145,000
2014-06-30	FOLD	PERCEPTIVE ADVISORS LLC	530,000	3.5000	530,000	3.5000	1,855,000

FOLD / Amicus Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री FOLD / Amicus Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2016-08-25	FOLD	PERCEPTIVE ADVISORS LLC	1,100,000	6.8100	1,100,000	6.8100	7,491,000	119	4.53	-2,508,000	-33.48

इनसाइडर खरीदारी LPTX / Leap Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2020-06-22	LPTX	PERCEPTIVE ADVISORS LLC	1,750,000	2.0000	175,000	20.0000	3,500,000	240	301	49,175,000	1,405.00

LPTX / Leap Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री LPTX / Leap Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी LYRA / Lyra Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2023-05-31	LYRA	PERCEPTIVE ADVISORS LLC	3,610,832	2.4925	72,217	124.6250	8,999,999	301	6.5300	-8,528,428	-94.76
2022-04-12	LYRA	PERCEPTIVE ADVISORS LLC	5,924,170	4.2200	118,483	211.0000	24,999,997
2020-05-05	LYRA	PERCEPTIVE ADVISORS LLC	625,000	16.0000	12,500	800.0000	10,000,000

LYRA / Lyra Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री LYRA / Lyra Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी MGTX / MeiraGTx Holdings plc - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2024-08-12	MGTX	PERCEPTIVE ADVISORS LLC	1,250,000	4.0000	1,250,000	4.0000	5,000,000	336	8.8900	6,112,500	122.25
2023-05-05	MGTX	PERCEPTIVE ADVISORS LLC	4,347,826	5.7500	4,347,826	5.7500	25,000,000
2020-11-23	MGTX	PERCEPTIVE ADVISORS LLC	500,000	12.8500	500,000	12.8500	6,425,000
2019-08-12	MGTX	PERCEPTIVE ADVISORS LLC	425,531	23.5000	425,531	23.5000	9,999,978
2019-03-01	MGTX	PERCEPTIVE LIFE SCIENCES MASTER FUND LTD	1,304,348	13.8000	1,304,348	13.8000	18,000,002
2018-06-12	MGTX	PERCEPTIVE ADVISORS LLC	1,333,333	15.0000	1,333,333	15.0000	19,999,995
2018-06-08	MGTX	PERCEPTIVE ADVISORS LLC	50,000	15.2200	50,000	15.2200	761,000

MGTX / MeiraGTx Holdings plc Insider Trades

इनसाइडर बिक्री MGTX / MeiraGTx Holdings plc - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी NAUT / Nautilus Biotechnology, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2021-12-08	NAUT	PERCEPTIVE ADVISORS LLC	200,000	5.3600	200,000	5.3600	1,072,000	15	6.04	136,000	12.69
2021-06-09	NAUT	PERCEPTIVE ADVISORS LLC	5,500,000	10.0000	5,500,000	10.0000	55,000,000
2021-06-03	ARYA	PERCEPTIVE ADVISORS LLC	330,050	10.0500	330,050	10.0500	3,317,002
2021-05-24	NAUT	PERCEPTIVE ADVISORS LLC	7,063	10.0500	7,063	10.0500	70,983
2021-05-20	ARYA	PERCEPTIVE ADVISORS LLC	159,925	10.0500	159,925	10.0500	1,607,246

NAUT / Nautilus Biotechnology, Inc. Insider Trades

इनसाइडर बिक्री NAUT / Nautilus Biotechnology, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी OBIO / Orchestra BioMed Holdings, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2025-08-01	OBIO	PERCEPTIVE ADVISORS LLC	700,000	2.7500	700,000	2.7500	1,925,000	25	3.0000	175,000	9.09

OBIO / Orchestra BioMed Holdings, Inc. Insider Trades

इनसाइडर बिक्री OBIO / Orchestra BioMed Holdings, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी SCYX / SCYNEXIS, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर बिक्री SCYX / SCYNEXIS, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2021-01-22	SCYX	PERCEPTIVE ADVISORS LLC	285,151	8.1600	285,151	8.1600	2,326,832	257	4.94	-918,186	-39.46
2021-01-22	SCYX	PERCEPTIVE ADVISORS LLC	33,849	8.9500	33,849	8.9500	302,949
2021-01-21	SCYX	PERCEPTIVE ADVISORS LLC	95,000	7.3800	95,000	7.3800	701,100
2021-01-20	SCYX	PERCEPTIVE ADVISORS LLC	185,000	7.4300	185,000	7.4300	1,374,550

इनसाइडर खरीदारी SLDB / Solid Biosciences Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2025-02-19	SLDB	PERCEPTIVE ADVISORS LLC	5,000,000	4.0300	5,000,000	4.0300	20,150,000	160	7.0700	15,200,000	75.43
2024-01-11	SLDB	PERCEPTIVE ADVISORS LLC	3,410,713	5.5300	3,410,713	5.5300	18,861,243
2021-03-23	SLDB	PERCEPTIVE ADVISORS LLC	2,608,695	5.7500	173,913	86.2500	14,999,996
2019-07-25	SLDB	PERCEPTIVE ADVISORS LLC	2,822,581	4.6500	188,172	69.7500	13,125,002
2018-01-30	SLDB	PERCEPTIVE ADVISORS LLC	1,000,000	16.0000	66,667	240.0000	16,000,000
2018-01-30	SLDB	PERCEPTIVE ADVISORS LLC	20,000	27.3260	1,333	409.8900	546,520

SLDB / Solid Biosciences Inc. Insider Trades

इनसाइडर बिक्री SLDB / Solid Biosciences Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी SLNO / Soleno Therapeutics, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2023-09-28	SLNO	PERCEPTIVE ADVISORS LLC	250,000	20.0000	250,000	20.0000	5,000,000	356	53.5500	8,387,500	167.75
2023-09-26	SLNO	PERCEPTIVE ADVISORS LLC	5,703	7.6500	5,703	7.6500	43,628
2023-09-26	SLNO	PERCEPTIVE ADVISORS LLC	13,687	8.3000	13,687	8.3000	113,602
2023-09-26	SLNO	PERCEPTIVE ADVISORS LLC	5,419	9.5200	5,419	9.5200	51,589
2023-09-26	SLNO	PERCEPTIVE ADVISORS LLC	37,911	11.0500	37,911	11.0500	418,917
2023-09-26	SLNO	PERCEPTIVE ADVISORS LLC	77,837	11.8100	77,837	11.8100	919,255
2023-09-26	SLNO	PERCEPTIVE ADVISORS LLC	42,838	12.8400	42,838	12.8400	550,040
2023-09-26	SLNO	PERCEPTIVE ADVISORS LLC	30,511	13.9200	30,511	13.9200	424,713
2023-09-26	SLNO	PERCEPTIVE ADVISORS LLC	3,326	14.6100	3,326	14.6100	48,593
2023-09-26	SLNO	PERCEPTIVE ADVISORS LLC	27,769	16.0000	27,769	16.0000	444,304
2023-09-26	SLNO	PERCEPTIVE ADVISORS LLC	75,477	17.2800	75,477	17.2800	1,304,243
2023-09-26	SLNO	PERCEPTIVE ADVISORS LLC	52,691	18.2400	52,691	18.2400	961,084
2023-09-26	SLNO	PERCEPTIVE ADVISORS LLC	88,685	19.1100	88,685	19.1100	1,694,770
2023-09-26	SLNO	PERCEPTIVE ADVISORS LLC	117,996	20.0300	117,996	20.0300	2,363,460
2023-09-26	SLNO	PERCEPTIVE ADVISORS LLC	36,939	21.0000	36,939	21.0000	775,719
2023-06-06	SLNO	PERCEPTIVE ADVISORS LLC	200	5.9300	200	5.9300	1,186
2023-06-05	SLNO	PERCEPTIVE ADVISORS LLC	78,468	5.9800	78,468	5.9800	469,239
2023-06-02	SLNO	PERCEPTIVE ADVISORS LLC	64,630	5.9300	64,630	5.9300	383,256
2023-06-01	SLNO	PERCEPTIVE ADVISORS LLC	7,500	5.5900	7,500	5.5900	41,925
2023-05-31	SLNO	PERCEPTIVE ADVISORS LLC	10,000	5.2800	10,000	5.2800	52,800
2023-05-30	SLNO	PERCEPTIVE ADVISORS LLC	17,500	5.3400	17,500	5.3400	93,450
2023-05-26	SLNO	PERCEPTIVE ADVISORS LLC	22,500	5.2700	22,500	5.2700	118,575
2023-05-25	SLNO	PERCEPTIVE ADVISORS LLC	37,500	5.1800	37,500	5.1800	194,250
2023-05-24	SLNO	PERCEPTIVE ADVISORS LLC	25,000	5.4800	25,000	5.4800	137,000
2023-05-23	SLNO	PERCEPTIVE ADVISORS LLC	27,500	5.4500	27,500	5.4500	149,875
2023-05-22	SLNO	PERCEPTIVE ADVISORS LLC	27,300	5.1200	27,300	5.1200	139,776
2023-05-19	SLNO	PERCEPTIVE ADVISORS LLC	25,200	4.6200	25,200	4.6200	116,424

SLNO / Soleno Therapeutics, Inc. Insider Trades

इनसाइडर बिक्री SLNO / Soleno Therapeutics, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी TLPH / Talphera, Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2013-11-07	ACRX	PERCEPTIVE ADVISORS LLC	93,500	6.4981	4,675	129.9620	607,572	118	260.6	610,733	100.52
2013-11-07	ACRX	PERCEPTIVE ADVISORS LLC	6,500	6.4981	325	129.9620	42,238
2013-11-06	ACRX	PERCEPTIVE ADVISORS LLC	93,500	6.5166	4,675	130.3320	609,302
2013-11-06	ACRX	PERCEPTIVE ADVISORS LLC	6,500	6.5166	325	130.3320	42,358
2013-11-04	ACRX	PERCEPTIVE ADVISORS LLC	98,175	6.8804	4,909	137.6080	675,483
2013-11-04	ACRX	PERCEPTIVE ADVISORS LLC	6,825	6.8804	341	137.6080	46,959
2013-11-04	ACRX	PERCEPTIVE ADVISORS LLC	46,750	6.8370	2,338	136.7400	319,630
2013-11-04	ACRX	PERCEPTIVE ADVISORS LLC	3,250	6.8370	162	136.7400	22,220
2013-11-01	ACRX	PERCEPTIVE ADVISORS LLC	10,442	7.1698	522	143.3960	74,867
2013-11-01	ACRX	PERCEPTIVE ADVISORS LLC	150,218	7.1698	7,511	143.3960	1,077,033
2013-10-31	ACRX	PERCEPTIVE ADVISORS LLC	192,000	6.6932	9,600	133.8640	1,285,094
2013-10-31	ACRX	PERCEPTIVE ADVISORS LLC	8,000	6.6932	400	133.8640	53,546
2013-07-23	ACRX	PERCEPTIVE ADVISORS LLC	850,000	11.6500	42,500	233.0000	9,902,500

इनसाइडर बिक्री TLPH / Talphera, Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2017-06-19	ACRX	PERCEPTIVE ADVISORS LLC	875,000	2.4000	43,750	48.0000	2,100,000	235	34	-612,500	-29.17
2016-09-29	ACRX	PERCEPTIVE ADVISORS LLC	97,200	3.8798	4,860	77.5960	377,117
2016-09-28	ACRX	PERCEPTIVE ADVISORS LLC	119,300	3.9596	5,965	79.1920	472,380
2016-09-15	ACRX	PERCEPTIVE ADVISORS LLC	276,927	3.7277	13,846	74.5540	1,032,301
2016-09-15	ACRX	PERCEPTIVE ADVISORS LLC	115,923	3.6275	5,796	72.5500	420,511
2015-11-18	ACRX	PERCEPTIVE ADVISORS LLC	42,300	5.3459	2,115	106.9180	226,132
2015-11-17	ACRX	PERCEPTIVE ADVISORS LLC	133,900	5.3578	6,695	107.1560	717,409
2015-11-06	ACRX	PERCEPTIVE ADVISORS LLC	17,100	4.4658	855	89.3160	76,365
2015-11-05	ACRX	PERCEPTIVE ADVISORS LLC	75,000	4.6168	3,750	92.3360	346,260
2015-09-09	ACRX	PERCEPTIVE ADVISORS LLC	310,000	4.1767	15,500	83.5340	1,294,777

इनसाइडर खरीदारी VRCA / Verrica Pharmaceuticals Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2023-12-29	VRCA	PERCEPTIVE ADVISORS LLC	115,774	7.2400	11,577	72.4000	838,204	136	9.5600	-727,527	-86.80
2023-12-28	VRCA	PERCEPTIVE ADVISORS LLC	126,116	7.0800	12,612	70.8000	892,901
2023-12-27	VRCA	PERCEPTIVE ADVISORS LLC	79,726	7.2000	7,973	72.0000	574,027
2023-12-26	VRCA	PERCEPTIVE ADVISORS LLC	54,652	6.4900	5,465	64.9000	354,691
2023-12-22	VRCA	PERCEPTIVE ADVISORS LLC	250,000	6.6700	25,000	66.7000	1,667,500
2023-12-21	VRCA	PERCEPTIVE ADVISORS LLC	200,000	6.1700	20,000	61.7000	1,234,000
2023-12-19	VRCA	PERCEPTIVE ADVISORS LLC	277,008	5.3600	27,701	53.6000	1,484,763
2023-12-18	VRCA	PERCEPTIVE ADVISORS LLC	456,923	5.4100	45,692	54.1000	2,471,953
2023-12-15	VRCA	PERCEPTIVE ADVISORS LLC	500,000	5.9700	50,000	59.7000	2,985,000
2022-07-05	VRCA	PERCEPTIVE ADVISORS LLC	1,428,571	2.1000	142,857	21.0000	2,999,999
2018-06-19	VRCA	PERCEPTIVE ADVISORS LLC	1,000,000	15.0000	100,000	150.0000	15,000,000

VRCA / Verrica Pharmaceuticals Inc. Insider Trades

इनसाइडर बिक्री VRCA / Verrica Pharmaceuticals Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
इस इनसाइडर और प्रतिभूति संयोजन के लिए कोई ज्ञात अनियोजित खुले बाज़ार व्यापार नहीं हैं

इनसाइडर खरीदारी VYNE / VYNE Therapeutics Inc. - अल्पकालिक लाभ विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन अधिकतम	मूल्य अधिकतम	अधिकतम लाभ ($)	अधिकतम रिटर्न (%)
2021-01-28	VYNE	PERCEPTIVE ADVISORS LLC	4,219,409	2.3700	383,583	26.0700	9,999,999	19	182.16	59,873,298	598.73
2020-06-09	MNLO	PERCEPTIVE ADVISORS LLC	2,702,702	1.8500	245,700	20.3500	4,999,999

VYNE / VYNE Therapeutics Inc. Insider Trades

इनसाइडर बिक्री VYNE / VYNE Therapeutics Inc. - अल्पकालिक हानि विश्लेषण

व्यापार की तिथि	टिकर	इनसाइडर	रिपोर्ट किए गए शेयर	रिपोर्ट की गई कीमत	समायोजित शेयर	समायोजित कीमत	मूल लागत	दिन न्यूनतम	मूल्य न्यूनतम	अधिकतम हानि बचाया ($)	अधिकतम हानि बचाया (%)
2021-08-16	VYNE	PERCEPTIVE ADVISORS LLC	250,000	1.7400	13,889	31.3200	435,000	360	5.472	-359,005	-82.53
2021-08-13	VYNE	PERCEPTIVE ADVISORS LLC	250,000	1.8400	13,889	33.1200	460,000
2021-08-12	VYNE	PERCEPTIVE ADVISORS LLC	338,897	2.2300	18,828	40.1400	755,740
2021-05-06	VYNE	PERCEPTIVE ADVISORS LLC	1,000,000	3.6700	55,556	66.0600	3,670,000

इनसाइडर व्यापार इतिहास

यह तालिका सिक्योरिटीज एक्सचेंज कमीशन (SEC) को बताए अनुसार Perceptive Advisors Llc द्वारा किए गए इनसाइडर व्यापारों की पूरी सूची दिखाती है।

फ़ाइल तिथि	ट्रांजेक्शन तिथि	फॉर्म	टिकर	प्रतिभूति	कोड	शेयर	शेष शेयर	प्रतिशत परिवर्तन	शेयर कीमत	ट्रांजेक्शन वैल्यू	शेष मूल्य
2025-08-05	2025-08-01	4	OBIO	Orchestra BioMed Holdings, Inc. Common Stock	P - Purchase	700,000	5,292,556	15.24	2.75	1,925,000	14,554,529
2025-05-01	2025-05-01	4	ACRV	Acrivon Therapeutics, Inc. Common Stock	S - Sale	-298,886	3,104,139	-8.78	1.34	-400,507	4,159,546
2025-05-01	2025-04-30	4	ACRV	Acrivon Therapeutics, Inc. Common Stock	S - Sale	-437,881	3,403,025	-11.40	1.41	-617,412	4,798,265
2025-04-29	2025-04-29	4	ACRV	Acrivon Therapeutics, Inc. Common Stock	S - Sale	-250,000	3,840,906	-6.11	1.41	-352,500	5,415,677
2025-04-29	2025-04-28	4	ACRV	Acrivon Therapeutics, Inc. Common Stock	S - Sale	-215,283	4,090,906	-5.00	1.56	-335,841	6,381,813
2025-04-29	2025-04-25	4	ACRV	Acrivon Therapeutics, Inc. Common Stock	S - Sale	-1,054,669	4,306,189	-19.67	1.95	-2,056,605	8,397,069
2025-04-07	2025-04-03	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	S - Sale	-3,400,000	5,875,851	-36.65	1.42	-4,828,000	8,343,708
2025-02-21	2025-02-19	4	SLDB	Solid Biosciences Inc. Common Stock	P - Purchase	5,000,000	11,833,539	73.17	4.03	20,150,000	47,689,162
2025-02-14	2025-01-22	4	ADGM	Adagio Medical Holdings, Inc. Common Stock	A - Award	64,167	9,675,684	0.67
2024-08-14	2024-08-12	4	MGTX	MeiraGTx Holdings plc Ordinary Shares	P - Purchase	1,250,000	12,531,103	11.08	4.00	5,000,000	50,124,412
2024-08-01		3	ADGM	Adagio Medical Holdings, Inc. Common stock			7,160,397
2024-07-17		3	OBIO	Orchestra BioMed Holdings, Inc. Common Stock, $0.0001 par value per share			4,592,556
2024-04-15	2024-04-11	4	ACRV	Acrivon Therapeutics, Inc. Common Stock	P - Purchase	2,353,000	5,360,858	78.23	8.50	20,000,500	45,567,293
2024-04-08	2024-04-05	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	37,712	9,275,851	0.41	4.74	178,755	43,967,534
2024-04-08	2024-04-04	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	140,281	9,238,139	1.54	4.67	655,112	43,142,109
2024-04-03	2024-04-03	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	309,847	9,097,858	3.53	4.09	1,267,274	37,210,239
2024-04-03	2024-04-02	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	186,051	8,788,011	2.16	3.44	640,015	30,230,758
2024-04-03	2024-04-01	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	8,374	8,601,960	0.10	3.25	27,216	27,956,370
2024-02-21	2024-02-20	4	CERE	Cerevel Therapeutics Holdings, Inc. Common Stock	G - Gift	-170,317	0	-100.00
2024-02-20	2024-02-15	4	LIAN	LianBio Ordinary Shares	F - Taxes	-19,218	17,082	-52.94	4.76	-91,478	81,310
2024-02-20	2024-02-15	4	LIAN	LianBio Ordinary Shares	F - Taxes	-19,218	17,082	-52.94	4.76	-91,478	81,310
2024-02-20	2024-02-15	4	LIAN	LianBio Ordinary Shares	M - Exercise	36,300	36,300		2.52	91,476	91,476
2024-02-20	2024-02-15	4	LIAN	LianBio Ordinary Shares	M - Exercise	36,300	36,300		2.52	91,476	91,476
2024-02-05	2024-02-01	4	ATXS	Astria Therapeutics, Inc. Common Stock	P - Purchase	2,481,350	4,873,721	103.72	12.09	29,999,522	58,923,287
2024-01-12	2024-01-11	4	SLDB	Solid Biosciences Inc. Common Stock	P - Purchase	3,410,713	6,833,539	99.65	5.53	18,861,243	37,789,471
2023-12-29	2023-12-29	4	ATHA	Athira Pharma, Inc. Common Stock	P - Purchase	163,954	5,402,964	3.13	2.38	390,211	12,859,054
2023-12-29	2023-12-28	4	ATHA	Athira Pharma, Inc. Common Stock	P - Purchase	409,598	5,239,010	8.48	2.44	999,419	12,783,184
2023-12-29	2023-12-27	4	ATHA	Athira Pharma, Inc. Common Stock	P - Purchase	32,134	4,829,412	0.67	2.28	73,266	11,011,059
2023-12-29	2023-12-29	4	VRCA	Verrica Pharmaceuticals Inc. Common Stock	P - Purchase	115,774	7,099,182	1.66	7.24	838,204	51,398,078
2023-12-29	2023-12-28	4	VRCA	Verrica Pharmaceuticals Inc. Common Stock	P - Purchase	126,116	6,983,408	1.84	7.08	892,901	49,442,529
2023-12-29	2023-12-27	4	VRCA	Verrica Pharmaceuticals Inc. Common Stock	P - Purchase	79,726	6,857,292	1.18	7.20	574,027	49,372,502
2023-12-26	2023-12-26	4	VRCA	Verrica Pharmaceuticals Inc. Common Stock	P - Purchase	54,652	6,777,566	0.81	6.49	354,691	43,986,403
2023-12-26	2023-12-22	4	VRCA	Verrica Pharmaceuticals Inc. Common Stock	P - Purchase	250,000	6,722,914	3.86	6.67	1,667,500	44,841,836
2023-12-26	2023-12-21	4	VRCA	Verrica Pharmaceuticals Inc. Common Stock	P - Purchase	200,000	6,472,914	3.19	6.17	1,234,000	39,937,879
2023-12-22	2023-12-21	4	ATXS	Astria Therapeutics, Inc. Common Stock	P - Purchase	740,000	2,392,371	44.78	6.20	4,588,000	14,832,700
2023-12-19	2023-12-19	4	VRCA	Verrica Pharmaceuticals Inc. Common Stock	P - Purchase	277,008	6,272,914	4.62	5.36	1,484,763	33,622,819
2023-12-19	2023-12-18	4	VRCA	Verrica Pharmaceuticals Inc. Common Stock	P - Purchase	456,923	5,995,906	8.25	5.41	2,471,953	32,437,851
2023-12-19	2023-12-15	4	VRCA	Verrica Pharmaceuticals Inc. Common Stock	P - Purchase	500,000	5,538,983	9.92	5.97	2,985,000	33,067,729
2023-11-14	2023-11-14	4	CRGX	CARGO Therapeutics, Inc. Common Stock	P - Purchase	333,333	333,333		15.00	4,999,995	4,999,995
2023-11-14	2023-11-14	4	CRGX	CARGO Therapeutics, Inc. Common Stock	P - Purchase	333,333	333,333		15.00	4,999,995	4,999,995
2023-11-14	2023-11-14	4	CRGX	CARGO Therapeutics, Inc. Common Stock	C - Conversion	2,579,502	2,579,502
2023-10-18	2023-10-16	4	ATXS	Astria Therapeutics, Inc. Common Stock	P - Purchase	460,546	1,611,699	40.01	6.51	2,999,997	10,498,607
2023-10-18	2023-10-16	4	ATXS	Astria Therapeutics, Inc. Common Stock	P - Purchase	614,062	1,652,371	59.14	6.51	4,000,000	10,763,545
2023-10-18	2023-10-18	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	S - Sale	-306,499	8,593,586	-3.44	1.74	-533,308	14,952,840
2023-10-18	2023-10-16	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	S - Sale	-2,450,000	8,900,085	-21.59	1.60	-3,920,000	14,240,136
2023-10-17	2023-10-16	4	CERE	Cerevel Therapeutics Holdings, Inc. Common Stock	P - Purchase	876,808	10,794,876	8.84	22.81	19,999,990	246,231,122
2023-09-28	2023-09-28	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	250,000	3,074,542	8.85	20.00	5,000,000	61,490,840
2023-09-28	2023-09-26	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	36,939	2,824,542	1.33	21.00	775,719	59,315,382
2023-09-28	2023-09-26	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	117,996	2,787,603	4.42	20.03	2,363,460	55,835,688
2023-09-28	2023-09-26	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	88,685	2,669,607	3.44	19.11	1,694,770	51,016,190
2023-09-28	2023-09-26	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	52,691	2,580,922	2.08	18.24	961,084	47,076,017
2023-09-28	2023-09-26	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	75,477	2,528,231	3.08	17.28	1,304,243	43,687,832
2023-09-28	2023-09-26	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	27,769	2,452,754	1.15	16.00	444,304	39,244,064
2023-09-28	2023-09-26	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	3,326	2,424,985	0.14	14.61	48,593	35,429,031
2023-09-28	2023-09-26	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	30,511	2,421,659	1.28	13.92	424,713	33,709,493
2023-09-28	2023-09-26	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	42,838	2,391,148	1.82	12.84	550,040	30,702,340
2023-09-28	2023-09-26	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	77,837	2,348,310	3.43	11.81	919,255	27,733,541
2023-09-28	2023-09-26	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	37,911	2,270,473	1.70	11.05	418,917	25,088,727
2023-09-28	2023-09-26	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	5,419	2,232,562	0.24	9.52	51,589	21,253,990
2023-09-28	2023-09-26	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	13,687	2,227,143	0.62	8.30	113,602	18,485,287
2023-09-28	2023-09-26	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	5,703	2,213,456	0.26	7.65	43,628	16,932,938
2023-06-06	2023-06-06	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	200	2,207,753	0.01	5.93	1,186	13,091,975
2023-06-06	2023-06-05	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	78,468	2,207,553	3.69	5.98	469,239	13,201,167
2023-06-06	2023-06-02	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	64,630	2,129,085	3.13	5.93	383,256	12,625,474
2023-06-02	2023-05-31	4	LYRA	Lyra Therapeutics, Inc. Common Stock	P - Purchase	3,610,832	11,469,117	45.95	2.49	8,999,999	28,586,774
2023-06-01	2023-06-01	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	7,500	2,064,455	0.36	5.59	41,925	11,540,303
2023-06-01	2023-05-31	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	10,000	2,056,955	0.49	5.28	52,800	10,860,722
2023-06-01	2023-05-30	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	17,500	2,046,955	0.86	5.34	93,450	10,930,740
2023-05-26	2023-05-26	4	SLNO	SOLENO THERAPEUTICS INC 210859	P - Purchase	22,500	2,029,455	1.12	5.27	118,575	10,695,228
2023-05-26	2023-05-25	4	SLNO	SOLENO THERAPEUTICS INC 210859	P - Purchase	37,500	2,006,955	1.90	5.18	194,250	10,396,027
2023-05-26	2023-05-24	4	SLNO	SOLENO THERAPEUTICS INC 210859	P - Purchase	25,000	1,969,455	1.29	5.48	137,000	10,792,613
2023-05-23	2023-05-23	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	27,500	1,944,455	1.43	5.45	149,875	10,597,280
2023-05-23	2023-05-22	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	27,300	1,916,955	1.44	5.12	139,776	9,814,810
2023-05-23	2023-05-19	4	SLNO	SOLENO THERAPEUTICS INC Common Stock	P - Purchase	25,200	1,889,655	1.35	4.62	116,424	8,730,206
2023-05-18		3	SLNO	SOLENO THERAPEUTICS INC Common Stock			1,864,455
2023-05-15	2023-05-05	4	MGTX	MeiraGTx Holdings plc Ordinary Shares	P - Purchase	4,347,826	11,281,103	62.71	5.75	25,000,000	64,866,342
2023-05-01	2023-04-27	4	CEMI	CHEMBIO DIAGNOSTICS, INC. Common Stock	U - Other	-5,162,782	0	-100.00	0.45	-2,323,252
2023-04-25	2023-04-25	4	CEMI	CHEMBIO DIAGNOSTICS, INC. Common Stock	P - Purchase	133,742	5,162,782	2.66	0.45	60,184	2,323,252
2023-04-25	2023-04-24	4	CEMI	CHEMBIO DIAGNOSTICS, INC. Common Stock	P - Purchase	39,506	5,029,040	0.79	0.45	17,778	2,263,068
2023-04-25	2023-04-21	4	CEMI	CHEMBIO DIAGNOSTICS, INC. Common Stock	P - Purchase	70,200	4,989,534	1.43	0.45	31,450	2,235,311
2023-04-20	2023-04-20	4	CEMI	CHEMBIO DIAGNOSTICS, INC. Common Stock	P - Purchase	56,000	4,919,334	1.15	0.45	25,200	2,213,700
2023-04-20	2023-04-19	4	CEMI	CHEMBIO DIAGNOSTICS, INC. Common Stock	P - Purchase	137,000	4,863,334	2.90	0.45	61,376	2,178,774
2023-04-20	2023-04-18	4	CEMI	CHEMBIO DIAGNOSTICS, INC. Common Stock	P - Purchase	15,800	4,726,334	0.34	0.45	7,078	2,117,398
2023-04-17	2023-04-17	4	CEMI	CHEMBIO DIAGNOSTICS, INC. Common Stock	P - Purchase	4,800	4,710,534	0.10	0.45	2,160	2,119,740
2023-04-17	2023-04-14	4	CEMI	CHEMBIO DIAGNOSTICS, INC. Common Stock	P - Purchase	11,500	4,705,734	0.24	0.45	5,175	2,117,580
2023-04-17	2023-04-13	4	CEMI	CHEMBIO DIAGNOSTICS, INC. Common Stock	P - Purchase	140,134	4,694,234	3.08	0.45	63,060	2,112,405
2023-04-13	2023-04-11	4	CEMI	CHEMBIO DIAGNOSTICS, INC. Common Stock	P - Purchase	129,000	4,554,100	2.92	0.44	56,760	2,003,804
2023-04-06	2023-04-06	4	VBIV	VBI Vaccines Inc/BC Common Stock	S - Sale	-4,251,563	41,440,729	-9.30	0.11	-467,672	4,558,480
2023-04-06	2023-04-05	4	VBIV	VBI Vaccines Inc/BC Common Stock	S - Sale	-1,832,563	45,691,816	-3.86	0.13	-238,233	5,939,936
2023-04-06	2023-04-04	4	VBIV	VBI Vaccines Inc/BC Common Stock	S - Sale	-4,810,623	47,524,379	-9.19	0.16	-769,700	7,603,901
2023-04-06		3	CEMI	CHEMBIO DIAGNOSTICS, INC. Common Stock			3,672,662
2023-04-06	2023-04-06	4	CEMI	CHEMBIO DIAGNOSTICS, INC. Common Stock	P - Purchase	339,000	4,425,100	8.30	0.44	149,160	1,947,044
2023-04-06	2023-04-05	4	CEMI	CHEMBIO DIAGNOSTICS, INC. Common Stock	P - Purchase	217,500	4,086,100	5.62	0.45	97,875	1,838,745
2023-04-06	2023-04-04	4	CEMI	CHEMBIO DIAGNOSTICS, INC. Common Stock	P - Purchase	195,938	3,868,600	5.34	0.44	86,213	1,702,184
2022-12-21	2022-12-19	4	ATXS	Astria Therapeutics, Inc. Common Stock	P - Purchase	908,265	1,038,309	698.43	11.01	9,999,998	11,431,782
2022-12-06	2022-12-02	4	SLDB	Solid Biosciences Inc. Common Stock	A - Award	73,107	73,107
2022-12-06	2022-12-02	4	SLDB	Solid Biosciences Inc. Common Stock	A - Award	365,536	3,422,826	11.96
2022-12-06	2022-12-02	4	SLDB	Solid Biosciences Inc. Common Stock	A - Award	2,163,120	3,057,290	241.91	7.05	15,249,996	21,553,894
2022-11-18		3	ACRV	Acrivon Therapeutics, Inc. Common Stock			3,007,858
2022-11-02	2022-10-31	4	QTNT	Quotient Ltd Ordinary Shares, nil par value	S - Sale	-8,255,607	7,945,211	-50.96	0.08	-660,449	635,617
2022-10-13	2022-10-13	4	ALBO	ALBIREO PHARMA, INC. Common Stock	S - Sale	-406	1,939,723	-0.02	22.79	-9,253	44,206,287
2022-10-13	2022-10-13	4	ALBO	ALBIREO PHARMA, INC. Common Stock	S - Sale	-178,726	1,940,129	-8.44	22.01	-3,933,759	42,702,239
2022-10-13	2022-10-12	4	ALBO	ALBIREO PHARMA, INC. Common Stock	S - Sale	-7,240	2,118,855	-0.34	23.23	-168,185	49,221,002
2022-10-13	2022-10-12	4	ALBO	ALBIREO PHARMA, INC. Common Stock	S - Sale	-89,979	2,126,095	-4.06	22.26	-2,002,933	47,326,875
2022-10-13	2022-10-11	4	ALBO	ALBIREO PHARMA, INC. Common Stock	S - Sale	-5,415	2,216,074	-0.24	24.78	-134,184	54,914,314
2022-10-13	2022-10-11	4	ALBO	ALBIREO PHARMA, INC. Common Stock	S - Sale	-38,310	2,221,489	-1.70	24.18	-926,336	53,715,604
2022-10-13	2022-10-11	4	ALBO	ALBIREO PHARMA, INC. Common Stock	S - Sale	-100,340	2,259,799	-4.25	23.23	-2,330,898	52,495,131
2022-08-22	2022-08-18	4	LIAN	LianBio American Depositary Shares	P - Purchase	998,240	3,728,491	36.56	2.40	2,395,776	8,948,378
2022-08-18	2022-08-16	4	CERE	Cerevel Therapeutics Holdings, Inc. Common Stock	P - Purchase	1,425,000	6,511,727	28.01	35.00	49,875,000	227,910,445
2022-08-11	2022-08-10	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	15,000	11,350,085	0.13	7.85	117,750	89,098,167
2022-08-11	2022-08-09	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	100,000	11,335,085	0.89	7.50	750,000	85,013,138
2022-08-10	2022-08-08	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	97,000	11,235,085	0.87	7.24	702,280	81,342,015
2022-08-09	2022-08-05	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	141,000	11,138,085	1.28	6.95	979,950	77,409,691
2022-08-08	2022-08-04	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	95,100	10,997,085	0.87	6.17	586,767	67,852,014
2022-08-05	2022-08-03	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	100,000	10,901,985	0.93	5.84	584,000	63,667,592
2022-08-04	2022-08-02	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	412,406	10,801,985	3.97	5.59	2,305,350	60,383,096
2022-08-03	2022-08-01	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	144,185	10,389,579	1.41	5.05	728,134	52,467,374
2022-08-02	2022-07-29	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	222,123	10,245,394	2.22	5.03	1,117,279	51,534,332
2022-08-01	2022-07-28	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	119,392	10,023,271	1.21	5.00	596,960	50,116,355
2022-07-05	2022-07-05	4	VRCA	Verrica Pharmaceuticals Inc. Common Stock	P - Purchase	1,428,571	5,038,983	39.57	2.10	2,999,999	10,581,864
2022-07-01	2022-06-30	4	ATHA	Athira Pharma, Inc. Common Stock	P - Purchase	1,101,362	4,797,278	29.80	2.99	3,293,072	14,343,861
2022-07-01	2022-06-29	4	ATHA	Athira Pharma, Inc. Common Stock	P - Purchase	270,000	3,695,916	7.88	2.99	807,300	11,050,789
2022-05-27	2022-05-26	4	LIAN	LianBio American Depositary Shares	P - Purchase	69,000	2,730,251	2.59	3.13	215,970	8,545,686
2022-05-27	2022-05-20	4	ATHA	Athira Pharma, Inc. Stock Option (Right to Buy)	A - Award	13,871	13,871
2022-05-25	2022-05-25	4	LIAN	LianBio American Depositary Shares	P - Purchase	120,000	2,661,251	4.72	2.63	315,600	6,999,090
2022-05-25	2022-05-24	4	LIAN	LianBio American Depositary Shares	P - Purchase	42,551	2,541,251	1.70	2.47	105,101	6,276,890
2022-05-25	2022-05-23	4	LIAN	LianBio American Depositary Shares	P - Purchase	8,700	2,498,700	0.35	2.49	21,663	6,221,763
2022-04-18	2022-04-18	4	CRNX	Crinetics Pharmaceuticals, Inc. Common Stock	P - Purchase	157,515	5,321,032	3.05	22.22	3,499,983	118,233,331
2022-04-14	2022-04-12	4	LYRA	Lyra Therapeutics, Inc. Common Stock	P - Purchase	5,924,170	7,858,285	306.30	4.22	24,999,997	33,161,963
2021-12-10	2021-12-08	4	NAUT	Nautilus Biotechnology, Inc. Common Stock	P - Purchase	200,000	9,111,151	2.24	5.36	1,072,000	48,835,769
2021-12-03	2021-12-01	4	VBIV	VBI Vaccines Inc/BC Common Stock	S - Sale	-2,707,463	52,334,993	-4.92	3.31	-8,961,703	173,228,827
2021-11-05	2021-11-03	4	LIAN	LianBio Ordinary Shares	P - Purchase	20,000	27,858,895	0.07	13.51	270,200	376,373,671
2021-11-05	2021-11-03	4	LIAN	LianBio Ordinary Shares	P - Purchase	2,250,000	27,838,895	8.79	16.00	36,000,000	445,422,320
2021-11-03	2021-11-03	4	LIAN	LianBio Series A Preferred Shares	C - Conversion	-423,579	0	-100.00
2021-11-03	2021-11-03	4	LIAN	LianBio Series Seed Preferred Shares	C - Conversion	-500,000	0	-100.00
2021-11-03	2021-11-03	4	LIAN	LianBio Series Seed Preferred Shares	C - Conversion	-2,500,000	0	-100.00
2021-11-03	2021-11-03	4	LIAN	LianBio Series Seed Preferred Shares	C - Conversion	-2,500,000	0	-100.00
2021-11-03	2021-11-03	4	LIAN	LianBio Series A Preferred Shares	C - Conversion	-635,369	0	-100.00
2021-11-03	2021-11-03	4	LIAN	LianBio Ordinary Shares	C - Conversion	2,477,005	2,477,005
2021-11-03	2021-11-03	4	LIAN	LianBio Ordinary Shares	C - Conversion	2,923,000	4,330,675	207.65
2021-11-03	2021-11-03	4	LIAN	LianBio Ordinary Shares	C - Conversion	14,619,500	21,653,385	207.84
2021-11-03	2021-11-03	4	LIAN	LianBio Ordinary Shares	C - Conversion	14,619,500	21,653,385	207.84
2021-11-03	2021-11-03	4	LIAN	LianBio Ordinary Shares	C - Conversion	3,715,510	10,969,395	51.22
2021-11-03	2021-11-02	4	LIAN	LianBio Ordinary Shares	P - Purchase	100,000	7,253,885	1.40	13.50	1,350,000	97,927,448
2021-11-03	2021-11-01	4	LIAN	LianBio Ordinary Shares	P - Purchase	120,000	7,153,885	1.71	15.50	1,860,000	110,885,218
2021-10-29		3	LIAN	LianBio Ordinary Shares			7,033,885
2021-10-29		3	LIAN	LianBio Ordinary Shares			7,033,885
2021-10-29		3	LIAN	LianBio Ordinary Shares			1,406,775
2021-10-25	2021-10-25	4	CRNX	Crinetics Pharmaceuticals, Inc. Common Stock	P - Purchase	1,200,000	5,163,517	30.28	19.80	23,760,000	102,237,637
2021-10-15	2021-10-13	4	AGRX	AGILE THERAPEUTICS INC Warrants (right to buy)	P - Purchase	2,687,280	2,687,280
2021-10-15	2021-10-13	4	AGRX	AGILE THERAPEUTICS INC Common Stock	P - Purchase	5,734,560	21,654,485	36.02	0.85	4,874,376	18,406,312
2021-10-14	2021-10-12	4	ISO	IsoPlexis Corp Series D Redeemable Convertible Preferred Stock	C - Conversion	-24,629	0	-100.00
2021-10-14	2021-10-12	4	ISO	IsoPlexis Corp Series D Redeemable Convertible Preferred Stock	C - Conversion	-40,373	0	-100.00
2021-10-14	2021-10-12	4	ISO	IsoPlexis Corp Series D Redeemable Convertible Preferred Stock	C - Conversion	-325,014	0	-100.00
2021-10-14	2021-10-12	4	ISO	IsoPlexis Corp Common Stock	P - Purchase	850,000	3,554,587	31.43	15.00	12,750,000	53,318,805
2021-10-14	2021-10-12	4	ISO	IsoPlexis Corp Common Stock	C - Conversion	204,949	204,949
2021-10-14	2021-10-12	4	ISO	IsoPlexis Corp Common Stock	C - Conversion	335,962	335,962
2021-10-14	2021-10-12	4	ISO	IsoPlexis Corp Common Stock	C - Conversion	2,704,587	2,704,587
2021-10-13	2021-10-12	4	RAIN	Rain Therapeutics Inc. Common Stock	S - Sale	-7,306	2,487,019	-0.29	13.40	-97,900	33,326,055
2021-10-13	2021-10-11	4	RAIN	Rain Therapeutics Inc. Common Stock	S - Sale	-9,351	2,494,325	-0.37	13.15	-122,966	32,800,374
2021-10-13	2021-10-11	4	RAIN	Rain Therapeutics Inc. Common Stock	S - Sale	-12,475	2,503,676	-0.50	12.03	-150,074	30,119,222
2021-10-13	2021-10-08	4	RAIN	Rain Therapeutics Inc. Common Stock	S - Sale	-2,462	2,516,151	-0.10	13.66	-33,631	34,370,623
2021-10-13	2021-10-08	4	RAIN	Rain Therapeutics Inc. Common Stock	S - Sale	-5,038	2,518,613	-0.20	12.90	-64,990	32,490,108
2021-10-13	2021-10-07	4	RAIN	Rain Therapeutics Inc. Common Stock	S - Sale	-286	2,523,651	-0.01	15.05	-4,304	37,980,948
2021-10-13	2021-10-07	4	RAIN	Rain Therapeutics Inc. Common Stock	S - Sale	-13,082	2,523,937	-0.52	14.80	-193,614	37,354,268
2021-09-30	2021-09-30	4	ADMA	ADMA BIOLOGICS, INC. Common Stock	S - Sale	-137,495	13,262,375	-1.03	1.12	-153,994	14,853,860
2021-09-30	2021-09-29	4	ADMA	ADMA BIOLOGICS, INC. Common Stock	S - Sale	-82,505	13,399,870	-0.61	1.16	-95,706	15,543,849
2021-09-30	2021-09-28	4	ADMA	ADMA BIOLOGICS, INC. Common Stock	S - Sale	-40,603	13,482,375	-0.30	1.22	-49,536	16,448,498
2021-09-29	2021-09-27	4	ADMA	ADMA BIOLOGICS, INC. Common Stock	S - Sale	-250,000	13,522,978	-1.82	1.23	-307,500	16,633,263
2021-09-29	2021-09-24	4	ADMA	ADMA BIOLOGICS, INC. Common Stock	S - Sale	-250,000	13,772,978	-1.78	1.26	-315,000	17,353,952
2021-09-28	2021-09-24	4	LPTX	LEAP THERAPEUTICS, INC. Warrants (right to buy)	P - Purchase	3,508,771	3,508,771		2.85	9,996,489	9,996,489
2021-09-28	2021-09-23	4	ADMA	ADMA BIOLOGICS, INC. Common Stock	S - Sale	-780,000	14,022,978	-5.27	1.27	-990,600	17,809,182
2021-08-31	2021-08-26	4	CERE	Cerevel Therapeutics Holdings, Inc. Common Stock	P - Purchase	68,047	5,086,727	1.36	30.23	2,057,061	153,771,757
2021-08-31	2021-08-27	4	LABP	Landos Biopharma, Inc. Stock Option (Right to Buy)	A - Award	25,291	25,291
2021-08-25	2021-08-25	4	CERE	Cerevel Therapeutics Holdings, Inc. Common Stock	P - Purchase	61,387	5,018,680	1.24	28.57	1,753,827	143,383,688
2021-08-25	2021-08-24	4	CERE	Cerevel Therapeutics Holdings, Inc. Common Stock	P - Purchase	69,761	4,957,293	1.43	27.73	1,934,473	137,465,735
2021-08-25	2021-08-23	4	CERE	Cerevel Therapeutics Holdings, Inc. Common Stock	P - Purchase	44,437	4,887,532	0.92	25.78	1,145,586	126,000,575
2021-08-19	2021-08-19	4	ADMA	ADMA BIOLOGICS, INC. Common Stock	S - Sale	-350,352	14,802,978	-2.31	1.24	-434,436	18,355,693
2021-08-19	2021-08-18	4	ADMA	ADMA BIOLOGICS, INC. Common Stock	S - Sale	-552,380	15,153,330	-3.52	1.29	-712,570	19,547,796
2021-08-19	2021-08-17	4	ADMA	ADMA BIOLOGICS, INC. Common Stock	S - Sale	-879,092	15,705,710	-5.30	1.35	-1,186,774	21,202,708
2021-08-18	2021-08-16	4	VYNE	VYNE Therapeutics Inc. Common Stock	S - Sale	-250,000	4,935,057	-4.82	1.74	-435,000	8,586,999
2021-08-17	2021-08-13	4	VYNE	VYNE Therapeutics Inc. Common Stock	S - Sale	-250,000	5,185,057	-4.60	1.84	-460,000	9,540,505
2021-08-16	2021-08-12	4	VYNE	VYNE Therapeutics Inc. Common Stock	S - Sale	-338,897	5,435,057	-5.87	2.23	-755,740	12,120,177
2021-07-09	2021-07-07	4	CERE	Cerevel Therapeutics Holdings, Inc. Common Stock	P - Purchase	200,000	4,843,095	4.31	25.00	5,000,000	121,077,375
2021-06-30	2021-06-29	4	VBIV	VBI Vaccines Inc/BC Common Stock	S - Sale	-145,548	0	-100.00	3.80	-553,082
2021-06-30	2021-06-29	4	VBIV	VBI Vaccines Inc/BC Common Stock	S - Sale	-500,709	0	-100.00	3.80	-1,902,694
2021-06-14	2021-06-10	4	MGTX	MeiraGTx Holdings plc Stock Option (right to buy)	A - Award	15,000	15,000
2021-06-14	2021-06-10	4	MGTX	MeiraGTx Holdings plc Restricted Share Units	A - Award	15,000	15,000
2021-06-11	2021-06-09	4	NAUT	Nautilus Biotechnology, Inc. Common Stock	J - Other	2,914,113	8,911,151	48.59
2021-06-11	2021-06-09	4	NAUT	Nautilus Biotechnology, Inc. Common Stock	P - Purchase	5,500,000	5,997,038	1,106.56	10.00	55,000,000	59,970,380
2021-06-11	2021-05-24	4	NAUT	Nautilus Biotechnology, Inc. Common Stock	P - Purchase	7,063	497,038	1.44	10.05	70,983	4,995,232
2021-06-11	2021-06-09	4	VBIV	VBI Vaccines Inc/BC Warrant (right to buy)	X - Other	-465,936	0	-100.00
2021-06-11	2021-06-09	4	VBIV	VBI Vaccines Inc/BC Warrant (right to buy)	X - Other	-1,602,888	0	-100.00
2021-06-11	2021-06-09	4	VBIV	VBI Vaccines Inc/BC Common Stock	S - Sale	-320,388	145,548	-68.76	4.00	-1,281,552	582,192
2021-06-11	2021-06-09	4	VBIV	VBI Vaccines Inc/BC Common Stock	S - Sale	-1,102,179	500,709	-68.76	4.00	-4,408,716	2,002,836
2021-06-11	2021-06-09	4	VBIV	VBI Vaccines Inc/BC Common Stock	X - Other	465,936	465,936		2.75	1,281,324	1,281,324
2021-06-11	2021-06-09	4	VBIV	VBI Vaccines Inc/BC Common Stock	X - Other	1,602,888	1,602,888		2.75	4,407,942	4,407,942
2021-06-03	2021-06-03	4	ARYA	ARYA Sciences Acquisition Corp III Class A Ordinary Shares	P - Purchase	330,050	489,975	206.38	10.05	3,317,002	4,924,249
2021-06-01	2021-05-28	4	ATHA	Athira Pharma, Inc. Stock Option (Right to Buy)	A - Award	13,871	13,871
2021-05-24	2021-05-20	4	ARYA	ARYA Sciences Acquisition Corp III Class A Ordinary Shares	P - Purchase	159,925	159,925		10.05	1,607,246	1,607,246
2021-05-07	2021-05-06	4	VYNE	VYNE Therapeutics Inc. Common Stock	S - Sale	-1,000,000	5,773,954	-14.76	3.67	-3,670,000	21,190,411
2021-05-04	2021-05-03	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	1,200,000	9,903,879	13.79	12.50	15,000,000	123,798,488
2021-04-27	2021-04-27	4	RAIN	Rain Therapeutics Inc. Series B Convertible Preferred Stock	C - Conversion	-1,195,792	0	-100.00
2021-04-27	2021-04-27	4	RAIN	Rain Therapeutics Inc. Series A Convertible Preferred Stock	C - Conversion	-949,992	0	-100.00
2021-04-27	2021-04-27	4	RAIN	Rain Therapeutics Inc. Common Stock	P - Purchase	550,000	2,537,019	27.68	17.00	9,350,000	43,129,323
2021-04-27	2021-04-27	4	RAIN	Rain Therapeutics Inc. Common Stock	C - Conversion	1,107,316	1,987,019	125.87
2021-04-27	2021-04-27	4	RAIN	Rain Therapeutics Inc. Common Stock	C - Conversion	879,703	879,703
2021-04-09	2021-04-08	4	CRNX	Crinetics Pharmaceuticals, Inc. Common Stock	P - Purchase	304,136	3,963,517	8.31	16.44	4,999,996	65,160,219
2021-04-06	2021-02-26	4	AGRX	AGILE THERAPEUTICS INC Warrants (right to buy)	J - Other	450,000	450,000
2021-03-23	2021-03-23	4	SLDB	Solid Biosciences Inc. Common Stock	P - Purchase	2,608,695	13,412,552	24.15	5.75	14,999,996	77,122,174
2021-03-16	2021-03-16	4	RXDX	Prometheus Biosciences, Inc. Series D-2 Convertible Preferred Stock	C - Conversion	-14,462,623	0	-100.00
2021-03-16	2021-03-16	4	RXDX	Prometheus Biosciences, Inc. Series D-1 Convertible Preferred Stock	C - Conversion	-10,177,703	0	-100.00
2021-03-16	2021-03-16	4	RXDX	Prometheus Biosciences, Inc. Common Stock	P - Purchase	850,000	3,314,032	34.50	19.00	16,150,000	62,966,608
2021-03-16	2021-03-16	4	RXDX	Prometheus Biosciences, Inc. Common Stock	C - Conversion	1,446,262	2,464,032	142.10
2021-03-16	2021-03-16	4	RXDX	Prometheus Biosciences, Inc. Common Stock	C - Conversion	1,017,770	1,017,770
2021-02-09	2021-02-09	4	LABP	Landos Biopharma, Inc. Common Stock	P - Purchase	34,951	7,299,751	0.48	14.60	510,285	106,576,365
2021-02-09	2021-02-09	4	LABP	Landos Biopharma, Inc. Common Stock	P - Purchase	64,730	7,264,800	0.90	13.80	893,274	100,254,240
2021-02-09	2021-02-08	4	LABP	Landos Biopharma, Inc. Common Stock	P - Purchase	1,771	7,200,070	0.02	13.10	23,200	94,320,917
2021-02-09	2021-02-08	4	LABP	Landos Biopharma, Inc. Common Stock	P - Purchase	86,671	7,198,299	1.22	12.53	1,085,988	90,194,686
2021-02-09	2021-02-08	4	LABP	Landos Biopharma, Inc. Common Stock	P - Purchase	34,611	7,111,628	0.49	11.38	393,873	80,930,327
2021-02-09	2021-02-05	4	LABP	Landos Biopharma, Inc. Common Stock	P - Purchase	27,453	7,077,017	0.39	11.14	305,826	78,837,969
2021-02-08	2021-02-08	4	LABP	Landos Biopharma, Inc. Series B Preferred Stock	C - Conversion	-1,770,600	0	-100.00
2021-02-08	2021-02-08	4	LABP	Landos Biopharma, Inc. Series B Preferred Stock	C - Conversion	-2,857,795	0	-100.00
2021-02-08	2021-02-08	4	LABP	Landos Biopharma, Inc. Series B Preferred Stock	C - Conversion	-2,857,795	0	-100.00
2021-02-08	2021-02-08	4	LABP	Landos Biopharma, Inc. Series A Preferred Stock	C - Conversion	-2,941,769	0	-100.00
2021-02-08	2021-02-08	4	LABP	Landos Biopharma, Inc. Series A Preferred Stock	C - Conversion	-2,941,769	0	-100.00
2021-02-08	2021-02-08	4	LABP	Landos Biopharma, Inc. Common Stock	P - Purchase	1,250,000	7,049,564	21.55	16.00	20,000,000	112,793,024
2021-02-08	2021-02-08	4	LABP	Landos Biopharma, Inc. Common Stock	C - Conversion	1,770,600	1,770,600
2021-02-08	2021-02-08	4	LABP	Landos Biopharma, Inc. Common Stock	C - Conversion	2,857,795	5,799,564	97.15
2021-02-08	2021-02-08	4	LABP	Landos Biopharma, Inc. Common Stock	C - Conversion	2,857,795	5,799,564	97.15
2021-02-08	2021-02-08	4	LABP	Landos Biopharma, Inc. Common Stock	C - Conversion	2,941,769	2,941,769
2021-02-08	2021-02-08	4	LABP	Landos Biopharma, Inc. Common Stock	C - Conversion	2,941,769	2,941,769
2021-02-03		3	LABP	Landos Biopharma, Inc. Common Stock			3,090,924
2021-02-03		3	CATB	CATABASIS PHARMACEUTICALS INC Common Stock			543,373
2021-02-03		3	CATB	CATABASIS PHARMACEUTICALS INC Common Stock			1,933,551
2021-02-03	2021-02-01	4	CATB	CATABASIS PHARMACEUTICALS INC Series X Convertible Preferred Stock	A - Award	1,617	30,920	5.52	3,009.53	4,866,410	93,054,668
2021-02-03	2021-02-01	4	CATB	CATABASIS PHARMACEUTICALS INC Series X Convertible Preferred Stock	A - Award	4,851	4,851		3,009.53	14,599,230	14,599,230
2021-02-01	2021-01-28	4	VYNE	VYNE Therapeutics Inc. Common Stock	P - Purchase	4,219,409	27,095,819	18.44	2.37	9,999,999	64,217,091
2021-01-27	2021-01-25	4	ATHA	Athira Pharma, Inc. Common Stock	P - Purchase	311,111	3,425,916	9.99	22.50	6,999,998	77,083,110
2021-01-26		3	SCYX	SCYNEXIS INC Common Stock			2,400,000
2021-01-26	2021-01-22	4	SCYX	SCYNEXIS INC Common Stock	S - Sale	-33,849	1,800,000	-1.85	8.95	-302,949	16,110,000
2021-01-26	2021-01-22	4	SCYX	SCYNEXIS INC Common Stock	S - Sale	-285,151	1,833,849	-13.46	8.16	-2,326,832	14,964,208
2021-01-26	2021-01-21	4	SCYX	SCYNEXIS INC Common Stock	S - Sale	-95,000	2,120,000	-4.29	7.38	-701,100	15,645,600
2021-01-26	2021-01-20	4	SCYX	SCYNEXIS INC Common Stock	S - Sale	-185,000	2,215,000	-7.71	7.43	-1,374,550	16,457,450
2021-01-22	2021-01-22	4	MOTS	Motus GI Holdings, Inc. Common Stock	S - Sale	-550,000	2,660,542	-17.13	1.48	-814,000	3,937,602
2021-01-22	2021-01-21	4	MOTS	Motus GI Holdings, Inc. Common Stock	S - Sale	-674,352	3,210,542	-17.36	1.68	-1,132,911	5,393,711
2021-01-22	2021-01-20	4	MOTS	Motus GI Holdings, Inc. Common Stock	S - Sale	-325,648	3,884,894	-7.73	1.80	-586,166	6,992,809
2021-01-21	2021-01-19	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	1,368,421	8,703,879	18.65	9.50	13,000,000	82,686,850
2021-01-11	2021-01-08	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	50,000	7,335,458	0.69	7.60	380,000	55,749,481
2021-01-11	2021-01-08	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	152,668	7,285,458	2.14	10.21	1,558,740	74,384,526
2021-01-11	2021-01-08	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	347,332	7,132,790	5.12	9.21	3,198,928	65,692,996
2021-01-11	2021-01-07	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	500,000	6,785,458	7.95	8.13	4,065,000	55,165,774
2020-12-15	2020-12-10	4	SLDB	Solid Biosciences Inc. Common Stock	A - Award	4,054,054	10,803,857	60.06	3.70	15,000,000	39,974,271
2020-11-24	2020-11-23	4	MGTX	MeiraGTx Holdings plc Ordinary Shares	P - Purchase	500,000	6,933,277	7.77	12.85	6,425,000	89,092,609
2020-10-29	2020-10-27	4	CERE	Cerevel Therapeutics Holdings, Inc. Common stock	P - Purchase	3,000,000	3,157,295	1,907.24	10.00	30,000,000	31,572,950
2020-10-22	2020-10-21	4	ARYB	ARYA Sciences Acquisition Corp II Class A ordinary shares	P - Purchase	43,195	157,295	37.86	10.09	435,838	1,587,107
2020-10-22	2020-10-20	4	ARYB	ARYA Sciences Acquisition Corp II Class A ordinary shares	P - Purchase	114,100	114,100		10.00	1,141,000	1,141,000
2020-09-22	2020-09-22	4	ATHA	Athira Pharma, Inc. Series B Preferred Stock	C - Conversion	-1,644,785	0	-100.00
2020-09-22	2020-09-22	4	ATHA	Athira Pharma, Inc. Common Stock	P - Purchase	1,058,824	3,114,805	51.50	17.00	18,000,008	52,951,685
2020-09-22	2020-09-22	4	ATHA	Athira Pharma, Inc. Common Stock	C - Conversion	1,644,785	2,055,981	400.00
2020-09-17		3	ATHA	Athira Pharma, Inc. Common Stock			411,196
2020-09-16	2020-09-15	4	QTNT	Quotient Ltd Ordinary Shares	P - Purchase	2,911,764	16,200,818	21.91	4.25	12,374,997	68,853,476
2020-09-15	2020-09-14	4	ALBO	ALBIREO PHARMA, INC. Common Stock	P - Purchase	400,000	2,360,139	20.41	40.00	16,000,000	94,405,560
2020-09-14	2020-09-14	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	1,800,000	13,532,467	15.34	11.00	19,800,000	148,857,137
2020-09-14	2020-09-10	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	200,000	11,732,467	1.73	11.24	2,248,000	131,872,929
2020-07-13	2020-07-09	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	3,200,000	6,285,458	103.71	4.25	13,600,000	26,713,196
2020-06-24	2020-06-22	4	LPTX	LEAP THERAPEUTICS, INC. Common Stock	P - Purchase	1,750,000	8,476,496	26.02	2.00	3,500,000	16,952,992
2020-06-18	2020-06-16	4	SLDB	Solid Biosciences Inc. Stock Option (Right to Buy)	A - Award	30,000	30,000
2020-06-11		3	MNLO	Menlo Therapeutics Inc. Common Stock			40,347,416
2020-06-11		3	MNLO	Menlo Therapeutics Inc. Common Stock			40,347,416
2020-06-11		3	MNLO	Menlo Therapeutics Inc. Common Stock			40,347,416
2020-06-11		3	MNLO	Menlo Therapeutics Inc. Common Stock			40,347,416
2020-06-11		3	MNLO	Menlo Therapeutics Inc. Common Stock			40,347,416
2020-06-11	2020-06-09	4	MNLO	Menlo Therapeutics Inc. Common Stock	P - Purchase	2,702,702	22,876,410	13.40	1.85	4,999,999	42,321,358
2020-06-04	2020-06-02	4	MGTX	MeiraGTx Holdings plc Stock Option (right to buy)	A - Award	25,000	25,000
2020-05-29	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	P - Purchase	625,000	1,934,115	47.74	16.00	10,000,000	30,945,840
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Warrants	X - Other	-339,604	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Warrants	X - Other	-141,221	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series C Convertible Preferred Stock	C - Conversion	-16,232,511	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series C Convertible Preferred Stock	C - Conversion	-39,035,325	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Series B Convertible Preferred Stock	C - Conversion	-26,666,666	0	-100.00
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	F - Taxes	-183,174	1,288,446	-12.45	16.00	-2,930,784	20,615,136
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	X - Other	339,604	1,471,620	30.00	8.63	2,930,783	12,700,081
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	F - Taxes	-76,172	1,309,115	-5.50	16.00	-1,218,752	20,945,840
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	X - Other	141,221	1,385,287	11.35	8.63	1,218,737	11,955,027
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	C - Conversion	470,739	1,244,066	60.87
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	C - Conversion	1,132,016	1,132,016
2020-05-06	2020-05-05	4	LYRA	Lyra Therapeutics, Inc. Common Stock	C - Conversion	773,327	773,327
2020-05-01	2020-04-30	4	LYRA	Lyra Therapeutics, Inc. Stock Option	A - Award	14,500	14,500
2020-05-01	2020-04-30	4	LYRA	Lyra Therapeutics, Inc. Stock Option	A - Award	14,500	14,500
2020-04-28	2020-04-24	4	VBIV	VBI Vaccines Inc/BC Common Stock	P - Purchase	9,090,909	55,042,456	19.78	1.10	10,000,000	60,546,702
2020-04-20		3	LPTX	LEAP THERAPEUTICS, INC. Common Stock			13,452,992
2020-04-20		3	LPTX	LEAP THERAPEUTICS, INC. Common Stock			13,452,992
2020-04-20		3	LPTX	LEAP THERAPEUTICS, INC. Common Stock			13,452,992
2020-04-20		3	LPTX	LEAP THERAPEUTICS, INC. Common Stock			13,452,992
2020-04-20		3	LPTX	LEAP THERAPEUTICS, INC. Common Stock			13,452,992
2020-04-20	2020-04-17	4	CRNX	Crinetics Pharmaceuticals, Inc. Common Stock	P - Purchase	1,071,428	3,659,381	41.40	14.00	14,999,992	51,231,334
2020-03-23	2020-03-19	4	ADMA	ADMA BIOLOGICS, INC. Common Stock	P - Purchase	500,000	16,584,802	3.11	2.10	1,050,000	34,828,084
2020-03-17	2020-03-13	4	AGRX	AGILE THERAPEUTICS INC Common Stock	P - Purchase	1,000,000	15,919,925	6.70	1.75	1,750,000	27,859,869
2020-02-25	2020-02-25	4	AGRX	AGILE THERAPEUTICS INC Common Stock	P - Purchase	3,000,000	14,919,925	25.17	3.00	9,000,000	44,759,775
2020-02-25	2020-02-10	4	AGRX	AGILE THERAPEUTICS INC Warrants (right to buy)	J - Other	700,000	700,000
2020-02-25	2020-02-10	4	AGRX	AGILE THERAPEUTICS INC Warrants (right to buy)	J - Other	700,000	700,000
2020-02-11	2020-02-11	4	ADMA	ADMA BIOLOGICS, INC. Common Stock	P - Purchase	4,563,700	16,084,802	39.61	3.50	15,972,950	56,296,807
2020-02-04	2020-02-03	4	ALBO	ALBIREO PHARMA, INC. Common Stock	P - Purchase	255,809	1,960,139	15.01	21.00	5,371,989	41,162,919
2019-12-27	2019-12-24	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	73,698	11,532,467	0.64	14.39	1,060,514	165,952,200
2019-12-26	2019-12-23	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	153,237	11,458,769	1.36	14.30	2,191,289	163,860,397
2019-12-26	2019-12-20	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	189,322	11,305,532	1.70	14.14	2,677,013	159,860,222
2019-12-26	2019-12-19	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	120,931	11,116,210	1.10	13.86	1,676,104	154,070,671
2019-12-26	2019-12-19	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	142,812	10,995,279	1.32	13.72	1,959,381	150,855,228
2019-11-18	2019-11-18	4	KDMN	Kadmon Holdings, Inc. Common Stock	P - Purchase	1,470,588	14,636,334	11.17	3.40	4,999,999	49,763,536
2019-11-18	2019-11-15	4	AGRX	AGILE THERAPEUTICS INC Common Stock	P - Purchase	333,800	11,919,925	2.88	1.74	580,812	20,740,670
2019-11-18	2019-11-15	4	AGRX	AGILE THERAPEUTICS INC Common Stock	P - Purchase	2,000,000	11,586,125	20.86	1.60	3,200,000	18,537,800
2019-11-18	2019-11-15	4	AGRX	AGILE THERAPEUTICS INC Common Stock	P - Purchase	3,000,000	9,586,125	45.55	1.72	5,160,000	16,488,135
2019-11-18	2019-11-14	4	AGRX	AGILE THERAPEUTICS INC Common Stock	P - Purchase	435,015	6,586,125	7.07	1.69	735,175	11,130,551
2019-11-15	2019-11-12	4	DOVA	Dova Pharmaceuticals Inc. Common Stock	J - Other	-3,125,851	0	-100.00
2019-11-12	2019-11-07	4	QTNT	Quotient Ltd Ordinary Shares	P - Purchase	2,500,000	13,289,054	23.17	7.00	17,500,000	93,023,378
2019-10-31	2019-10-29	4	AGRX	AGILE THERAPEUTICS INC Common Stock	S - Sale	-760,291	6,151,110	-11.00	0.44	-334,528	2,706,488
2019-10-30	2019-10-28	4	AGRX	AGILE THERAPEUTICS INC Common Stock	S - Sale	-3,815,349	6,911,401	-35.57	0.51	-1,945,828	3,524,815
2019-10-30	2019-08-06	4	AGRX	AGILE THERAPEUTICS INC Common Stock	P - Purchase	2,300,000	10,726,750	27.29	0.95	2,185,000	10,190,412
2019-10-21	2019-10-17	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	50,000	10,852,467	0.46	10.93	546,500	118,617,464
2019-10-18	2019-10-16	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	67,222	10,802,467	0.63	10.29	691,714	111,157,385
2019-09-24	2019-09-23	4	VBIV	VBI Vaccines Inc/BC Common Stock	P - Purchase	20,000,000	45,951,556	77.07	0.50	10,000,000	22,975,778
2019-09-18	2019-09-16	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	30,000	10,735,245	0.28	13.58	407,400	145,784,627
2019-09-16	2019-09-13	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	56,416	10,705,245	0.53	14.27	805,056	152,763,846
2019-09-16	2019-09-12	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	13,584	10,648,829	0.13	14.05	190,855	149,616,047
2019-08-20	2019-08-12	4	MGTX	MeiraGTx Holdings plc Ordinary Shares	P - Purchase	425,531	6,433,277	7.08	23.50	9,999,978	151,182,010
2019-08-16	2019-08-16	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	20,000	10,635,245	0.19	14.96	299,200	159,103,265
2019-08-16	2019-08-15	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	30,000	10,615,245	0.28	15.00	450,000	159,228,675
2019-08-09	2019-08-08	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	30,000	10,585,245	0.28	15.76	472,800	166,823,461
2019-08-09	2019-08-07	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	37,764	10,555,245	0.36	15.79	596,294	166,667,319
2019-08-09	2019-08-07	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	248,752	10,517,481	2.42	15.04	3,741,230	158,182,914
2019-08-09	2019-08-07	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	371,756	10,268,729	3.76	14.14	5,256,630	145,199,828
2019-08-09	2019-08-07	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	74,855	9,896,973	0.76	13.12	982,098	129,848,286
2019-08-09	2019-06-25	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	1,495	9,822,118	0.02	17.89	26,746	175,717,691
2019-08-09	2019-06-24	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	20,786	9,820,623	0.21	17.90	372,069	175,789,152
2019-08-09	2019-06-21	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	23,073	9,799,837	0.24	17.85	411,853	174,927,090
2019-08-06		3	FOMX	Foamix Pharmaceuticals Ltd. Common Stock			22,407,762
2019-08-06		3	FOMX	Foamix Pharmaceuticals Ltd. Common Stock			22,407,762
2019-08-06		3	FOMX	Foamix Pharmaceuticals Ltd. Common Stock			22,407,762
2019-08-06		3	FOMX	Foamix Pharmaceuticals Ltd. Common Stock			22,407,762
2019-08-06		3	FOMX	Foamix Pharmaceuticals Ltd. Common Stock			22,407,762
2019-07-29	2019-07-25	4	SLDB	Solid Biosciences Inc. Common Stock	P - Purchase	2,822,581	6,749,803	71.87	4.65	13,125,002	31,386,584
2019-07-11	2019-07-11	4	DOVA	Dova Pharmaceuticals Inc. Common Stock	P - Purchase	42,916	3,708,705	1.17	16.67	715,410	61,824,112
2019-07-11	2019-07-10	4	DOVA	Dova Pharmaceuticals Inc. Common Stock	P - Purchase	12,354	3,665,789	0.34	16.89	208,659	61,915,176
2019-07-11	2019-07-09	4	DOVA	Dova Pharmaceuticals Inc. Common Stock	P - Purchase	29,834	3,653,435	0.82	16.61	495,543	60,683,555
2019-07-09	2019-07-05	4	DOVA	Dova Pharmaceuticals Inc. Common Stock	P - Purchase	50,000	3,632,601	1.40	16.46	823,000	59,792,612
2019-07-03	2019-07-03	4	DOVA	Dova Pharmaceuticals Inc. Common Stock	P - Purchase	1,705	3,573,601	0.05	16.67	28,422	59,571,929
2019-07-03	2019-07-02	4	DOVA	Dova Pharmaceuticals Inc. Common Stock	P - Purchase	715	3,571,896	0.02	16.14	11,540	57,650,401
2019-07-03	2019-07-01	4	DOVA	Dova Pharmaceuticals Inc. Common Stock	P - Purchase	18,121	3,571,181	0.51	14.24	258,043	50,853,617
2019-07-01	2019-06-28	4	DOVA	Dova Pharmaceuticals Inc. Common Stock	P - Purchase	39,383	3,553,060	1.12	14.48	570,266	51,448,309
2019-07-01	2019-06-28	4	DOVA	Dova Pharmaceuticals Inc. Common Stock	P - Purchase	60,617	3,513,560	1.76	13.97	846,819	49,084,433
2019-07-01	2019-06-27	4	DOVA	Dova Pharmaceuticals Inc. Common Stock	P - Purchase	186,696	3,453,060	5.72	13.58	2,535,332	46,892,555
2019-07-01	2019-06-27	4	DOVA	Dova Pharmaceuticals Inc. Common Stock	P - Purchase	140,513	3,266,364	4.50	12.46	1,750,792	40,698,895
2019-07-01	2019-06-27	4	MOTS	Motus GI Holdings, Inc. Common Stock	P - Purchase	1,000,000	4,210,542	31.15	3.00	3,000,000	12,631,626
2019-06-21	2019-06-19	4	MGTX	MeiraGTx Holdings plc Stock Option (right to buy)	A - Award	25,000	25,000
2019-06-20	2019-06-18	4	VBIV	VBI Vaccines Inc/BC Common Stock	P - Purchase	1,000,000	25,951,556	4.01	0.65	650,000	16,868,511
2019-06-20	2019-06-18	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	50,742	9,776,764	0.52	17.73	899,656	173,342,026
2019-06-19	2019-06-17	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	130,000	9,726,022	1.35	17.94	2,332,200	174,484,835
2019-06-18	2019-06-17	4	VBIV	VBI Vaccines Inc/BC Common Stock	P - Purchase	1,000,000	24,951,556	4.18	0.62	618,000	15,420,062
2019-06-18	2019-06-14	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	324,290	9,596,022	3.50	17.69	5,736,690	169,753,629
2019-06-17	2019-06-13	4	SLDB	Solid Biosciences Inc. Stock Option (Right to Buy)	A - Award	10,000	10,000
2019-06-17	2019-06-13	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	75,710	9,271,732	0.82	17.05	1,290,856	158,083,031
2019-05-23	2019-05-21	4	ADMA	ADMA BIOLOGICS, INC. Common Stock	P - Purchase	4,000,000	11,521,102	53.18	4.00	16,000,000	46,084,408
2019-05-23	2019-05-03	4	ADMA	ADMA BIOLOGICS, INC. Warrants (right to buy)	P - Purchase	250,000	250,000
2019-05-23	2019-02-11	4	ADMA	ADMA BIOLOGICS, INC. Warrants (right to buy)	P - Purchase	1,360,000	1,360,000
2019-05-08		3	ATNX	Athenex, Inc. Common Stock			18,192,044
2019-05-08		3	ATNX	Athenex, Inc. Common Stock			18,192,044
2019-05-08		3	ATNX	Athenex, Inc. Common Stock			18,192,044
2019-05-08		3	ATNX	Athenex, Inc. Common Stock			18,192,044
2019-05-08		3	ATNX	Athenex, Inc. Common Stock			18,192,044
2019-05-08	2019-05-06	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	77,010	9,196,022	0.84	12.90	993,429	118,628,684
2019-05-08	2019-05-06	4	ATNX	Athenex, Inc. Common Stock	P - Purchase	22,990	9,119,012	0.25	12.08	277,719	110,157,665
2019-03-06		3	AGRX	AGILE THERAPEUTICS INC Common Stock			16,853,500
2019-03-06		3	AGRX	AGILE THERAPEUTICS INC Common Stock			16,853,500
2019-03-06		3	AGRX	AGILE THERAPEUTICS INC Common Stock			16,853,500
2019-03-06		3	AGRX	AGILE THERAPEUTICS INC Common Stock			16,853,500
2019-03-06		3	AGRX	AGILE THERAPEUTICS INC Common Stock			16,853,500
2019-03-05	2019-03-01	4	MGTX	MeiraGTx Holdings plc Ordinary Shares	P - Purchase	1,304,348	6,007,746	27.73	13.80	18,000,002	82,906,895
2019-01-17	2018-12-24	4	MOTS	Motus GI Holdings, Inc. Common Stock	P - Purchase	400,000	3,210,541	14.23	2.70	1,080,000	8,668,461
2019-01-17	2018-02-14	4	MOTS	Motus GI Holdings, Inc. Common Stock	P - Purchase	10,000	2,810,541	0.36	5.00	50,000	14,052,705
2019-01-09	2019-01-08	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	S - Sale	-450,235	2,253,376	-16.65	5.26	-2,368,236	11,852,758
2019-01-09	2019-01-08	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	S - Sale	-800,000	2,703,611	-22.83	5.25	-4,200,000	14,193,958
2019-01-09	2019-01-07	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	S - Sale	-25,800	3,503,611	-0.73	6.46	-166,668	22,633,327
2019-01-09	2019-01-07	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	S - Sale	-25,800	3,503,611	-0.73	6.46	-166,668	22,633,327
2019-01-09	2019-01-07	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	S - Sale	-4,200	3,529,411	-0.12	5.26	-22,092	18,564,702
2019-01-09	2019-01-07	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	S - Sale	-4,200	3,529,411	-0.12	5.26	-22,092	18,564,702
2019-01-09	2019-01-07	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	S - Sale	-4,592	3,563,611	-0.13	9.52	-43,716	33,925,577
2019-01-09	2019-01-07	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	S - Sale	-34,401	3,568,203	-0.95	9.05	-311,329	32,292,237
2019-01-09	2019-01-07	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	S - Sale	-131,866	3,602,604	-3.53	7.56	-996,907	27,235,686
2019-01-09	2019-01-07	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	S - Sale	-147,497	3,734,470	-3.80	6.67	-983,805	24,908,915
2019-01-09	2019-01-07	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	S - Sale	-431,644	3,881,967	-10.01	5.64	-2,434,472	21,894,294
2018-12-17	2018-12-13	4	VBIV	VBI Vaccines Inc/BC Common Stock	P - Purchase	14,285,714	23,631,439	152.86	1.40	20,000,000	33,084,015
2018-12-10	2018-12-07	4	QTNT	Quotient Ltd Ordinary Shares	P - Purchase	2,000,000	10,789,054	22.76	6.50	13,000,000	70,128,851
2018-10-15	2018-10-12	4	CORI	Corium International, Inc. Common Stock	S - Sale	-2,350,000	2,724,686	-46.31	12.52	-29,422,000	34,113,069
2018-10-15	2018-10-12	4	CORI	Corium International, Inc. Common Stock	S - Sale	-500,000	5,074,686	-8.97	12.51	-6,255,000	63,484,322
2018-10-15	2018-10-11	4	CORI	Corium International, Inc. Common Stock	S - Sale	-500,000	5,574,686	-8.23	12.50	-6,250,000	69,683,575
2018-10-15	2018-10-11	4	CORI	Corium International, Inc. Common Stock	S - Sale	-282,447	6,074,686	-4.44	12.51	-3,533,412	75,994,322
2018-10-05	2018-10-03	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	30,000	20,724,424	0.14	12.69	380,700	262,992,941
2018-10-05	2018-09-24	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	20,000	20,694,424	0.10	12.45	249,000	257,645,579
2018-09-25	2018-09-21	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	50,000	20,674,424	0.24	12.53	626,500	259,050,533
2018-09-17	2018-09-13	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	100,000	20,624,424	0.49	11.74	1,174,000	242,130,738
2018-09-14	2018-09-12	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	500,000	20,524,424	2.50	12.00	6,001,500	246,354,661
2018-08-27	2018-07-20	4/A	CRNX	Crinetics Pharmaceuticals, Inc. Series B Preferred Stock	C - Conversion	-6,186,205	0	-100.00
2018-08-27	2018-07-20	4/A	CRNX	Crinetics Pharmaceuticals, Inc. Common Stock	P - Purchase	400,000	2,587,953	18.28	17.00	6,800,000	43,995,201
2018-08-27	2018-07-20	4/A	CRNX	Crinetics Pharmaceuticals, Inc. Common Stock	C - Conversion	1,880,305	2,187,953	611.19
2018-08-27	2018-07-18	4/A	CRNX	Crinetics Pharmaceuticals, Inc. Common Stock	P - Purchase	307,648	307,648		21.30	6,552,902	6,552,902
2018-08-14	2018-08-10	4	ZGNX	ZOGENIX, INC. Common Stock	P - Purchase	100,000	4,070,357	2.52	52.00	5,200,000	211,658,564
2018-08-01	2018-06-19	4	VRCA	Verrica Pharmaceuticals Inc. Series C Preferred Stock	C - Conversion	-2,193,463	0	-100.00
2018-08-01	2018-06-19	4	VRCA	Verrica Pharmaceuticals Inc. Series B Preferred Stock	C - Conversion	-1,937,984	0	-100.00
2018-08-01	2018-06-19	4	VRCA	Verrica Pharmaceuticals Inc. Common Stock	P - Purchase	1,000,000	3,410,412	41.49	15.00	15,000,000	51,156,180
2018-08-01	2018-06-19	4	VRCA	Verrica Pharmaceuticals Inc. Common Stock	C - Conversion	1,279,733	2,410,412	113.18
2018-08-01	2018-06-19	4	VRCA	Verrica Pharmaceuticals Inc. Common Stock	C - Conversion	1,130,679	1,130,679
2018-07-27	2018-07-25	4	SLDB	Solid Biosciences Inc. Stock Option (Right to Buy)	A - Award	1,835	1,835
2018-07-26	2018-07-26	4	AGRX	AGILE THERAPEUTICS INC Common Stock	S - Sale	-298,628	3,231,372	-8.46	0.30	-89,439	967,796
2018-07-20	2018-07-18	4	QTNT	Quotient Ltd Warrants (right to buy)	X - Other	-2,306,034	0	-100.00
2018-07-20	2018-07-18	4	QTNT	Quotient Ltd Ordinary Shares	X - Other	2,306,034	8,789,054	35.57	5.80	13,374,997	50,976,513
2018-07-20	2018-07-20	4	CRNX	Crinetics Pharmaceuticals, Inc. Series B Preferred Stock	C - Conversion	-6,186,205	0	-100.00
2018-07-20	2018-07-20	4	CRNX	Crinetics Pharmaceuticals, Inc. Common Stock	P - Purchase	400,000	2,280,305	21.27	17.00	6,800,000	38,765,185
2018-07-20	2018-07-20	4	CRNX	Crinetics Pharmaceuticals, Inc. Common Stock	C - Conversion	1,880,305	1,880,305
2018-06-22		3	KDMN	Kadmon Holdings, Inc. Common Stock			26,331,492
2018-06-22		3	KDMN	Kadmon Holdings, Inc. Common Stock			26,331,492
2018-06-22		3	KDMN	Kadmon Holdings, Inc. Common Stock			26,331,492
2018-06-22		3	KDMN	Kadmon Holdings, Inc. Common Stock			26,331,492
2018-06-22		3	KDMN	Kadmon Holdings, Inc. Common Stock			26,331,492
2018-06-13	2018-06-11	4	DOVA	Dova Pharmaceuticals, Inc. Common Stock	P - Purchase	5,591	3,125,851	0.18	29.82	166,724	93,212,877
2018-06-13	2018-06-11	4	DOVA	Dova Pharmaceuticals, Inc. Common Stock	P - Purchase	14,109	3,120,260	0.45	29.18	411,701	91,049,187
2018-06-12	2018-06-08	4	DOVA	Dova Pharmaceuticals, Inc. Common Stock	P - Purchase	2,000	3,106,151	0.06	28.97	57,940	89,985,194
2018-06-12	2018-06-08	4	DOVA	Dova Pharmaceuticals, Inc. Common Stock	P - Purchase	23,000	3,104,151	0.75	28.62	658,260	88,840,802
2018-06-12	2018-06-12	4	MGTX	MeiraGTx Holdings plc Ordinary Shares	P - Purchase	1,333,333	4,703,398	39.56	15.00	19,999,995	70,550,970
2018-06-12	2018-06-08	4	MGTX	MeiraGTx Holdings plc Ordinary Shares	P - Purchase	50,000	3,370,065	1.51	15.22	761,000	51,292,389
2018-06-11	2018-06-07	4	DOVA	Dova Pharmaceuticals, Inc. Common Stock	P - Purchase	8,400	3,081,151	0.27	29.16	244,944	89,846,363
2018-06-11	2018-06-07	4	DOVA	Dova Pharmaceuticals, Inc. Common Stock	P - Purchase	19,223	3,072,751	0.63	28.40	545,933	87,266,128
2018-06-11	2018-06-07	4	DOVA	Dova Pharmaceuticals, Inc. Common Stock	P - Purchase	22,377	3,053,528	0.74	27.63	618,277	84,368,979
2018-06-08	2018-06-06	4	DOVA	Dova Pharmaceuticals, Inc. Common Stock	P - Purchase	51,763	3,031,151	1.74	28.99	1,500,609	87,873,067
2018-06-08	2018-06-06	4	DOVA	Dova Pharmaceuticals, Inc. Common Stock	P - Purchase	48,237	2,979,388	1.65	28.30	1,365,107	84,316,680
2018-06-08		3	MGTX	MeiraGTx Holdings plc Ordinary shares			6,640,130
2018-06-08		3	MGTX	MeiraGTx Holdings plc Ordinary shares			6,640,130
2018-06-08		3	MGTX	MeiraGTx Holdings plc Ordinary shares			6,640,130
2018-06-08		3	MGTX	MeiraGTx Holdings plc Ordinary shares			6,640,130
2018-06-08		3	MGTX	MeiraGTx Holdings plc Ordinary shares			6,640,130
2018-06-07	2018-06-05	4	DOVA	Dova Pharmaceuticals, Inc. Common Stock	P - Purchase	3,168	2,931,151	0.11	27.13	85,948	79,522,127
2018-06-07	2018-06-05	4	DOVA	Dova Pharmaceuticals, Inc. Common Stock	P - Purchase	56,162	2,927,983	1.96	26.31	1,477,622	77,035,233
2018-06-07	2018-06-05	4	DOVA	Dova Pharmaceuticals, Inc. Common Stock	P - Purchase	40,670	2,871,821	1.44	25.45	1,035,052	73,087,844
2018-06-06	2018-06-04	4	DOVA	Dova Pharmaceuticals, Inc. Common Stock	P - Purchase	10,000	2,831,151	0.35	25.07	250,700	70,976,956
2018-06-06		3	DOVA	Dova Pharmaceuticals, Inc. Common Stock			5,642,302
2018-06-06		3	DOVA	Dova Pharmaceuticals, Inc. Common Stock			5,642,302
2018-06-06		3	DOVA	Dova Pharmaceuticals, Inc. Common Stock			5,642,302
2018-06-06		3	DOVA	Dova Pharmaceuticals, Inc. Common Stock			5,642,302
2018-06-06		3	DOVA	Dova Pharmaceuticals, Inc. Common Stock			5,642,302
2018-05-24	2018-05-23	4	QTNT	Quotient Ltd Ordinary Shares	P - Purchase	231,992	6,483,020	3.71	6.65	1,542,747	43,112,083
2018-05-24	2018-05-22	4	QTNT	Quotient Ltd Ordinary Shares	P - Purchase	218,008	6,251,028	3.61	6.24	1,360,370	39,006,415
2018-03-28		3	AGRX	AGILE THERAPEUTICS INC Common Stock			7,060,000
2018-03-28		3	AGRX	AGILE THERAPEUTICS INC Common Stock			7,060,000
2018-03-28		3	AGRX	AGILE THERAPEUTICS INC Common Stock			7,060,000
2018-03-28		3	AGRX	AGILE THERAPEUTICS INC Common Stock			7,060,000
2018-03-28		3	AGRX	AGILE THERAPEUTICS INC Common Stock			7,060,000
2018-03-26	2018-03-15	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	700,000	4,313,611	19.37	29.50	20,650,000	127,251,524
2018-03-07	2018-03-05	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	335,827	18,424,424	1.86	13.56	4,553,814	249,835,189
2018-03-06	2018-03-02	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	100,000	18,088,597	0.56	13.90	1,389,500	251,341,055
2018-03-05	2018-03-01	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	100,000	17,988,597	0.56	13.69	1,369,000	246,263,893
2018-02-21	2018-02-16	4	MOTS	Motus GI Holdings, Inc. Series A Convertible Preferred Stock	C - Conversion	-256,386	0	-100.00
2018-02-21	2018-02-16	4	MOTS	Motus GI Holdings, Inc. Common Stock	P - Purchase	1,000,000	2,800,541	55.54	5.00	5,000,000	14,002,705
2018-02-21	2018-02-16	4	MOTS	Motus GI Holdings, Inc. Common Stock	C - Conversion	256,386	1,800,541	16.60
2018-02-21	2018-02-16	4	MOTS	Motus GI Holdings, Inc. Warrant (right to buy)	J - Other	180,055	180,055
2018-02-20	2018-02-15	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	50,000	3,613,611	1.40	32.42	1,621,000	117,153,269
2018-02-15	2018-02-14	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	100,000	3,563,611	2.89	32.69	3,269,000	116,494,444
2018-02-15	2018-02-13	4	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock	P - Purchase	75,000	3,463,611	2.21	32.75	2,456,250	113,433,260
2018-02-13		3	MOTS	Motus GI Holdings, Inc. Common Stock			3,088,310
2018-02-13		3	MOTS	Motus GI Holdings, Inc. Common Stock			3,088,310
2018-02-13		3	MOTS	Motus GI Holdings, Inc. Common Stock			3,088,310
2018-02-13		3	MOTS	Motus GI Holdings, Inc. Common Stock			3,088,310
2018-01-30	2018-01-30	4	SLDB	Solid Biosciences Inc. Common Stock	P - Purchase	20,000	3,927,222	0.51	27.33	546,520	107,315,268
2018-01-30	2018-01-30	4	SLDB	Solid Biosciences Inc. Common Stock	P - Purchase	1,000,000	3,907,222	34.40	16.00	16,000,000	62,515,552
2018-01-25	2018-01-25	4	ALBO	ALBIREO PHARMA, INC. Common Stock	P - Purchase	275,000	1,595,000	20.83	33.00	9,075,000	52,635,000
2018-01-25		3	SLDB	Solid Biosciences, LLC Common Stock			5,814,444
2018-01-25		3	SLDB	Solid Biosciences, LLC Common Stock			5,814,444
2018-01-25		3	SLDB	Solid Biosciences, LLC Common Stock			5,814,444
2018-01-25		3	SLDB	Solid Biosciences, LLC Common Stock			5,814,444
2018-01-18	2018-01-18	4	CORI	Corium International, Inc. Common Stock	P - Purchase	310,000	6,357,133	5.13	12.80	3,968,000	81,371,302
2018-01-18	2018-01-17	4	CORI	Corium International, Inc. Common Stock	P - Purchase	149,650	6,047,133	2.54	12.24	1,831,716	74,016,908
2018-01-18	2018-01-16	4	CORI	Corium International, Inc. Common Stock	P - Purchase	50,350	5,897,483	0.86	11.83	595,640	69,767,224
2017-12-19	2017-12-19	4	GBT	Global Blood Therapeutics, Inc. Common Stock	P - Purchase	175,000	4,889,066	3.71	38.00	6,650,000	185,784,508
2017-12-18		3	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock			6,777,222
2017-12-18		3	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock			6,777,222
2017-12-18		3	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock			6,777,222
2017-12-18		3	LJPC	LA JOLLA PHARMACEUTICAL CO Common Stock			6,777,222
2017-12-15		3	GBT	Global Blood Therapeutics, Inc. Common Stock			9,428,132
2017-12-15		3	GBT	Global Blood Therapeutics, Inc. Common Stock			9,428,132
2017-12-15		3	GBT	Global Blood Therapeutics, Inc. Common Stock			9,428,132
2017-12-15		3	GBT	Global Blood Therapeutics, Inc. Common Stock			9,428,132
2017-12-04		3	ALBO	ALBIREO PHARMA, INC. Common stock			2,640,000
2017-12-04		3	ALBO	ALBIREO PHARMA, INC. Common stock			2,640,000
2017-12-04		3	ALBO	ALBIREO PHARMA, INC. Common stock			2,640,000
2017-12-04		3	ALBO	ALBIREO PHARMA, INC. Common stock			2,640,000
2017-11-15		3	ADMA	ADMA BIOLOGICS, INC. Common stock, par value $0.0001 per share			7,642,204
2017-11-15		3	ADMA	ADMA BIOLOGICS, INC. Common stock, par value $0.0001 per share			7,642,204
2017-11-15		3	ADMA	ADMA BIOLOGICS, INC. Common stock, par value $0.0001 per share			7,642,204
2017-11-15		3	ADMA	ADMA BIOLOGICS, INC. Common stock, par value $0.0001 per share			7,642,204
2017-11-01		3/A	QTNT	Quotient Ltd Ordinary Shares			6,033,020
2017-10-30	2017-10-26	4	VBIV	VBI Vaccines Inc/BC Common Stock	P - Purchase	3,100,000	9,345,725	49.63	3.05	9,455,000	28,504,461
2017-10-26		3	QTNT	Quotient Ltd Ordinary Shares			12,086,040
2017-10-26		3	QTNT	Quotient Ltd Ordinary Shares			12,086,040
2017-10-26		3	QTNT	Quotient Ltd Ordinary Shares			12,086,040
2017-10-26		3	QTNT	Quotient Ltd Ordinary Shares			12,086,040
2017-10-03	2017-09-29	4	ZGNX	ZOGENIX, INC. Common Stock	P - Purchase	22,055	3,670,357	0.60	27.67	610,341	101,571,991
2017-10-03	2017-09-29	4	ZGNX	ZOGENIX, INC. Common Stock	P - Purchase	8,920	3,648,302	0.25	40.14	358,081	146,455,976
2017-10-03	2017-09-29	4	ZGNX	ZOGENIX, INC. Common Stock	P - Purchase	12,586	3,639,382	0.35	39.22	493,600	142,730,011
2017-10-03	2017-09-29	4	ZGNX	ZOGENIX, INC. Common Stock	P - Purchase	8,112	3,626,796	0.22	38.56	312,791	139,845,990
2017-10-03	2017-09-29	4	ZGNX	ZOGENIX, INC. Common Stock	P - Purchase	6,153	3,618,684	0.17	37.14	228,530	134,402,266
2017-10-03	2017-09-29	4	ZGNX	ZOGENIX, INC. Common Stock	P - Purchase	3,800	3,612,531	0.11	36.26	137,805	131,006,630
2017-10-03	2017-09-29	4	ZGNX	ZOGENIX, INC. Common Stock	P - Purchase	6,000	3,608,731	0.17	34.91	209,475	125,989,821
2017-10-03	2017-09-29	4	ZGNX	ZOGENIX, INC. Common Stock	P - Purchase	8,260	3,602,731	0.23	33.86	279,665	121,980,185
2017-10-03	2017-09-29	4	ZGNX	ZOGENIX, INC. Common Stock	P - Purchase	15,937	3,594,471	0.45	32.96	525,311	118,479,875
2017-10-03	2017-09-29	4	ZGNX	ZOGENIX, INC. Common Stock	P - Purchase	102,199	3,578,534	2.94	31.90	3,260,240	114,158,455
2017-10-03	2017-09-29	4	ZGNX	ZOGENIX, INC. Common Stock	P - Purchase	28,033	3,476,335	0.81	31.19	874,220	108,410,898
2017-10-03	2017-10-03	4	ZGNX	ZOGENIX, INC. Common Stock	P - Purchase	300,000	3,970,357	8.17	37.50	11,250,000	148,888,388
2017-09-25	2017-09-22	4	VSAR	Versartis, Inc. Common Stock	S - Sale	-350,000	2,099,563	-14.29	3.35	-1,172,500	7,033,536
2017-09-25	2017-09-22	4	VSAR	Versartis, Inc. Common Stock	S - Sale	-500,000	2,449,563	-16.95	3.27	-1,633,250	8,001,498
2017-09-25	2017-09-22	4	VSAR	Versartis, Inc. Common Stock	S - Sale	-250,000	2,949,563	-7.81	3.17	-792,500	9,350,115
2017-09-25	2017-09-22	4	VSAR	Versartis, Inc. Common Stock	S - Sale	-250,000	3,199,563	-7.25	3.03	-757,250	9,691,476
2017-09-25	2017-09-22	4	VSAR	Versartis, Inc. Common Stock	S - Sale	-300,000	3,449,563	-8.00	3.09	-926,250	10,650,526
2017-09-25	2017-09-21	4	VSAR	Versartis, Inc. Common Stock	S - Sale	-353,421	3,749,563	-8.61	3.56	-1,258,143	13,348,069
2017-09-25	2017-09-21	4	VSAR	Versartis, Inc. Common Stock	S - Sale	-126,579	4,102,984	-2.99	3.74	-473,659	15,353,366
2017-09-21	2017-09-19	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	200,000	3,085,458	6.93	7.25	1,450,000	22,369,570
2017-07-14	2017-07-13	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	1,500,000	17,888,597	9.15	12.25	18,375,000	219,135,313
2017-07-05	2017-06-30	4	CORI	Corium International, Inc. Common Stock	P - Purchase	301,004	5,847,133	5.43	7.70	2,319,236	45,052,160
2017-07-05	2017-06-30	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	296,007	2,885,458	11.43	4.60	1,361,632	13,273,107
2017-07-05	2017-06-30	4	ZGNX	ZOGENIX, INC. Common Stock	P - Purchase	175,653	3,448,302	5.37	14.45	2,538,186	49,827,964
2017-06-21	2017-06-19	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	S - Sale	-875,000	4,533,728	-16.18	2.40	-2,100,000	10,880,947
2017-05-25	2017-05-25	4	CORI	Corium International, Inc. Common Stock	P - Purchase	1,902,400	5,546,129	52.21	6.25	11,890,000	34,663,306
2017-05-25		3	CORI	Corium International, Inc. Common Stock			7,287,458
2017-05-25		3	CORI	Corium International, Inc. Common Stock			7,287,458
2017-05-25		3	CORI	Corium International, Inc. Common Stock			7,287,458
2017-05-25		3	CORI	Corium International, Inc. Common Stock			7,287,458
2017-05-18		3	ZGNX	ZOGENIX, INC. Common Stock			6,545,298
2017-05-18		3	ZGNX	ZOGENIX, INC. Common Stock			6,545,298
2017-05-18		3	ZGNX	ZOGENIX, INC. Common Stock			6,545,298
2017-05-18		3	ZGNX	ZOGENIX, INC. Common Stock			6,545,298
2017-03-14	2017-02-13	4/A	VSAR	Versartis, Inc. Common Stock	P - Purchase	59,133	4,229,563	1.42	15.51	917,425	65,619,978
2017-03-14	2017-02-10	4/A	VSAR	Versartis, Inc. Common Stock	P - Purchase	34,883	4,170,430	0.84	14.94	521,281	62,321,655
2017-02-15	2017-02-14	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	893,025	2,589,451	52.64	4.50	4,018,612	11,652,530
2017-02-14	2017-02-13	4	VSAR	Versartis, Inc. Common Stock	P - Purchase	59,133	4,228,563	1.42	15.51	917,425	65,604,464
2017-02-14	2017-02-10	4	VSAR	Versartis, Inc. Common Stock	P - Purchase	34,883	4,169,430	0.84	14.94	521,281	62,306,711
2017-02-10	2017-02-09	4	VSAR	Versartis, Inc. Common Stock	P - Purchase	41,211	4,134,547	1.01	14.27	587,928	58,984,688
2017-02-10	2017-02-08	4	VSAR	Versartis, Inc. Common Stock	P - Purchase	104,612	4,093,336	2.62	13.51	1,413,319	55,301,379
2017-01-04	2016-12-30	4	VSAR	Versartis, Inc. Common Stock	P - Purchase	94,750	4,013,411	2.42	14.66	1,388,846	58,828,578
2017-01-04	2016-12-30	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	94,750	16,293,847	0.58	4.96	470,055	80,833,775
2017-01-04	2016-12-30	4/A	VSAR	Versartis, Inc. Common Stock	P - Purchase	71,063	3,989,724	1.81	14.66	1,041,641	58,481,374
2016-12-30	2016-12-29	4	VSAR	Versartis, Inc. Common Stock	P - Purchase	47,375	3,918,661	1.22	14.37	680,589	56,295,484
2016-12-30	2016-12-29	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	94,750	16,293,847	0.58	4.85	459,916	79,090,333
2016-12-30	2016-12-28	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	47,375	16,199,097	0.29	4.91	232,706	79,569,964
2016-12-27	2016-12-23	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	37,900	16,151,722	0.24	4.92	186,582	79,514,927
2016-12-27	2016-12-23	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	47,375	16,113,822	0.29	4.72	223,468	76,008,898
2016-12-23	2016-12-22	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	189,500	16,066,447	1.19	4.51	854,834	72,475,742
2016-12-08	2016-12-06	4	VBIV	VBI VACCINES INC. Warrant	P - Purchase	1,341,282	2,068,824	184.36	3.36	4,500,001	6,940,905
2016-12-08	2016-12-06	4	VBIV	VBI VACCINES INC. Warrant	P - Purchase	363,771	727,542	100.00	4.13	1,502,374	3,004,748
2016-12-08	2016-12-06	4	VBIV	VBI VACCINES INC. Common Stock	P - Purchase	3,383,955	6,213,314	119.60	3.05	10,321,063	18,950,608
2016-12-02		3	FOLD	AMICUS THERAPEUTICS INC Common Stock			26,447,894
2016-12-02		3	FOLD	AMICUS THERAPEUTICS INC Common Stock			26,447,894
2016-12-02		3	FOLD	AMICUS THERAPEUTICS INC Common Stock			26,447,894
2016-12-02		3	FOLD	AMICUS THERAPEUTICS INC Common Stock			26,447,894
2016-12-02		3/A	FOLD	AMICUS THERAPEUTICS INC Common Stock			15,876,947
2016-10-05		3/A	VSAR	Versartis, Inc. Common Stock			3,871,286
2016-09-30	2016-09-29	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	S - Sale	-97,200	5,386,410	-1.77	3.88	-377,117	20,898,194
2016-09-30	2016-09-28	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	S - Sale	-119,300	5,483,610	-2.13	3.96	-472,380	21,712,902
2016-09-28		3	VSAR	Versartis, Inc. Common Stock			7,594,838
2016-09-28		3	VSAR	Versartis, Inc. Common Stock			7,594,838
2016-09-28		3	VSAR	Versartis, Inc. Common Stock			7,594,838
2016-09-28		3	VSAR	Versartis, Inc. Common Stock			7,594,838
2016-09-16	2016-09-15	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	S - Sale	-115,923	5,602,910	-2.03	3.63	-420,511	20,324,556
2016-09-16	2016-09-15	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	S - Sale	-276,927	5,718,833	-4.62	3.73	-1,032,301	21,318,094
2016-08-26	2016-08-25	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	S - Sale	-1,100,000	14,139,444	-7.22	6.81	-7,491,000	96,289,614
2016-05-26	2016-05-26	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	700,000	1,940,458	56.43	5.00	3,500,000	9,702,290
2015-11-19	2015-11-18	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	S - Sale	-42,300	5,995,760	-0.70	5.35	-226,132	32,052,733
2015-11-19	2015-11-17	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	S - Sale	-133,900	6,038,060	-2.17	5.36	-717,409	32,350,718
2015-11-09	2015-11-06	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	S - Sale	-17,100	6,171,960	-0.28	4.47	-76,365	27,562,739
2015-11-09	2015-11-05	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	S - Sale	-75,000	6,189,060	-1.20	4.62	-346,260	28,573,652
2015-11-05	2015-10-28	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	45,100	1,240,458	3.77	6.50	293,150	8,062,977
2015-10-28	2015-10-26	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	50,000	1,195,358	4.37	6.46	323,150	7,725,599
2015-10-26	2015-10-22	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	18,020	1,145,358	1.60	6.47	116,661	7,415,048
2015-10-22	2015-10-20	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	22,797	1,127,338	2.06	6.44	146,858	7,262,311
2015-10-22	2015-10-20	4	ALDX	Aldeyra Therapeutics, Inc. Common Stock	P - Purchase	14,348	1,104,541	1.32	6.30	90,335	6,954,190
2015-10-22		3	ALDX	Aldeyra Therapeutics, Inc. Common Stock			2,180,386
2015-10-22		3	ALDX	Aldeyra Therapeutics, Inc. Common Stock			2,180,386
2015-10-22		3	ALDX	Aldeyra Therapeutics, Inc. Common Stock			2,180,386
2015-10-22		3	ALDX	Aldeyra Therapeutics, Inc. Common Stock			2,180,386
2015-10-08	2015-10-07	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	50,000	15,239,444	0.33	6.27	313,500	95,551,314
2015-10-07	2015-10-06	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	7,000	15,189,444	0.05	6.34	44,380	96,301,075
2015-10-07	2015-10-06	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	14,000	15,182,444	0.09	6.47	90,580	98,230,413
2015-10-07	2015-10-06	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	14,000	15,168,444	0.09	6.65	93,100	100,870,153
2015-10-07	2015-10-06	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	43,000	15,154,444	0.28	6.34	272,620	96,079,175
2015-10-07	2015-10-06	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	86,000	15,111	-121.32	6.47	556,420	97,771
2015-10-07	2015-10-06	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	86,000	15,025,444	0.58	6.65	571,900	99,919,203
2015-10-07	2015-10-05	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	35,000	14,939,444	0.23	6.76	236,600	100,990,641
2015-10-07	2015-10-05	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	35,000	14,904,444	0.24	6.85	239,750	102,095,441
2015-10-07	2015-10-05	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	215,000	14,869,444	1.47	6.76	1,453,400	100,517,441
2015-10-07	2015-10-05	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	215,000	14,654,444	1.49	6.85	1,472,750	100,382,941
2015-09-11	2015-09-09	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	S - Sale	-310,000	6,264,060	-4.72	4.18	-1,294,777	26,163,099
2015-08-18	2015-08-14	4	VBIV	VBI VACCINES INC. Common Stock	P - Purchase	650,000	3,260,356	24.90	2.08	1,352,000	6,781,540
2014-11-19	2014-11-19	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	2,100,000	14,439,444	17.02	6.50	13,650,000	93,856,386
2014-07-01	2014-06-30	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	530,000	12,339,444	4.49	3.50	1,855,000	43,188,054
2014-07-01	2014-06-30	4	FOLD	AMICUS THERAPEUTICS INC Common Stock	P - Purchase	3,470,000	11,809,444	41.61	3.50	12,145,000	41,333,054
2014-05-30		3	FOLD	AMICUS THERAPEUTICS INC Common Stock			16,678,888
2014-05-30		3	FOLD	AMICUS THERAPEUTICS INC Common Stock			16,678,888
2014-05-30		3	FOLD	AMICUS THERAPEUTICS INC Common Stock			16,678,888
2014-05-30		3	FOLD	AMICUS THERAPEUTICS INC Common Stock			16,678,888
2013-11-12	2013-11-07	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	P - Purchase	6,500	6,574,060	0.10	6.50	42,238	42,718,899
2013-11-12	2013-11-07	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	P - Purchase	93,500	6,567,560	1.44	6.50	607,572	42,676,662
2013-11-12	2013-11-06	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	P - Purchase	6,500	6,474,060	0.10	6.52	42,358	42,188,859
2013-11-12	2013-11-06	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	P - Purchase	93,500	6,467,560	1.47	6.52	609,302	42,146,501
2013-11-06	2013-11-04	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	P - Purchase	3,250	6,374,060	0.05	6.84	22,220	43,579,448
2013-11-06	2013-11-04	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	P - Purchase	46,750	6,370,810	0.74	6.84	319,630	43,557,228
2013-11-06	2013-11-04	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	P - Purchase	6,825	6,324,060	0.11	6.88	46,959	43,512,062
2013-11-06	2013-11-04	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	P - Purchase	98,175	6,317,235	1.58	6.88	675,483	43,465,104
2013-11-04	2013-11-01	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	P - Purchase	150,218	6,219,060	2.48	7.17	1,077,033	44,589,416
2013-11-04	2013-11-01	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	P - Purchase	10,442	6,068,842	0.17	7.17	74,867	43,512,383
2013-11-04	2013-10-31	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	P - Purchase	8,000	6,058,400	0.13	6.69	53,546	40,550,083
2013-11-04	2013-10-31	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	P - Purchase	192,000	6,050,400	3.28	6.69	1,285,094	40,496,537
2013-09-09	2013-09-05	4	AEGR	Aegerion Pharmaceuticals, Inc. Common Stock	S - Sale	-50,000	2,823,426	-1.74	89.20	-4,460,000	251,849,599
2013-09-09	2013-09-05	4	AEGR	Aegerion Pharmaceuticals, Inc. Common Stock	S - Sale	-700,000	2,873,426	-19.59	89.20	-62,440,000	256,309,599
2013-09-09	2013-06-15	4	AEGR	Aegerion Pharmaceuticals, Inc. Call option (right to buy)	X - Other	-1,000	0	-100.00
2013-09-09	2013-06-15	4	AEGR	Aegerion Pharmaceuticals, Inc. Call option (right to buy)	X - Other	-1,000	0	-100.00
2013-09-09	2013-06-15	4	AEGR	Aegerion Pharmaceuticals, Inc. Common Stock	X - Other	100,000	3,573,426	2.88	25.00	2,500,000	89,335,650
2013-09-09	2013-06-15	4	AEGR	Aegerion Pharmaceuticals, Inc. Common Stock	X - Other	100,000	3,473,426	2.96	25.00	2,500,000	86,835,650
2013-07-24	2013-07-23	4	ACRX	ACELRX PHARMACEUTICALS INC Common Stock	P - Purchase	850,000	5,858,400	16.97	11.65	9,902,500	68,250,360
2013-03-20	2013-03-16	4	RPRX	REPROS THERAPEUTICS INC. Call option (right to sell)	E - Other	500	22,000	2.33
2013-03-20	2013-03-16	4	RPRX	REPROS THERAPEUTICS INC. Call option (right to sell)	E - Other	500	22,000	2.33
2013-03-20	2013-03-16	4	RPRX	REPROS THERAPEUTICS INC. Call option (right to sell)	E - Other	500	22,500	2.27
2013-03-20	2013-03-16	4	RPRX	REPROS THERAPEUTICS INC. Call option (right to sell)	E - Other	500	23,000	2.22
2013-03-20	2013-03-16	4	RPRX	REPROS THERAPEUTICS INC. Call option (right to sell)	E - Other	500	23,500	2.17
2013-03-20	2013-03-16	4	RPRX	REPROS THERAPEUTICS INC. Call option (right to sell)	E - Other	1,000	24,000	4.35
2013-03-20	2013-03-16	4	RPRX	REPROS THERAPEUTICS INC. Call option (right to sell)	E - Other	1,000	24,000	4.35
2013-03-20	2013-03-16	4	RPRX	REPROS THERAPEUTICS INC. Call option (right to sell)	E - Other	1,000	25,000	4.17
2013-03-20	2013-03-16	4	RPRX	REPROS THERAPEUTICS INC. Call option (right to sell)	E - Other	1,500	26,000	6.12
2013-03-20	2013-03-16	4	RPRX	REPROS THERAPEUTICS INC. Call option (right to sell)	E - Other	2,000	27,500	7.84
2013-03-20	2013-03-16	4	RPRX	REPROS THERAPEUTICS INC. Call option (right to sell)	E - Other	2,000	27,500	7.84
2013-03-20	2013-03-16	4	RPRX	REPROS THERAPEUTICS INC. Call option (right to sell)	E - Other	6,000	29,500	25.53
2013-03-20	2013-03-16	4	RPRX	REPROS THERAPEUTICS INC. Call option (right to sell)	E - Other	1,000	36,000	2.86
2013-03-20	2013-03-16	4	RPRX	REPROS THERAPEUTICS INC. Call option (right to sell)	E - Other	4,000	40,000	11.11
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	X - Other	500	44,000	1.15
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	X - Other	500	44,000	1.15
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	X - Other	500	44,500	1.14
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	X - Other	500	45,000	1.12
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	X - Other	1,000	45,500	2.25
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	X - Other	1,000	45,500	2.25
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	X - Other	500
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	X - Other	1,000	47,500	2.15
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	X - Other	1,000	48,500	2.11
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	X - Other	1,500	49,500	3.12
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	X - Other	1,500	49,500	3.12
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	X - Other	4,000	51,000	8.51
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	X - Other	4,000	51,000	8.51
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	X - Other	1,000	55,000	1.85
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	X - Other	2,000	56,000	3.70
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	X - Other	-50,000	812,560	-5.80	10.00	-500,000	8,125,600
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	X - Other	-50,000	812,560	-5.80	10.00	-500,000	8,125,600
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	X - Other	-50,000	862,560	-5.48	12.50	-625,000	10,782,000
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	X - Other	-50,000	862,560	-5.48	12.50	-625,000	10,782,000
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	X - Other	-50,000	862,560	-5.48	12.50	-625,000	10,782,000
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	X - Other	-100,000	962,560	-9.41	12.50	-1,250,000	12,032,000
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	X - Other	-100,000	962,560	-9.41	12.50	-1,250,000	12,032,000
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	X - Other	-100,000	962,560	-9.41	12.50	-1,250,000	12,032,000
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	X - Other	-100,000	1,162,560	-7.92	10.00	-1,000,000	11,625,600
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	X - Other	-150,000	1,362,560	-9.92	12.50	-1,875,000	17,032,000
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	X - Other	-400,000	1,512,560	-20.91	12.50	-5,000,000	18,907,000
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	X - Other	-400,000	1,512,560	-20.91	12.50	-5,000,000	18,907,000
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	X - Other	-200,000	2,012,560	-9.04	12.50	-2,500,000	25,157,000
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	X - Other	-150,000	2,612,560	-5.43	15.00	-2,250,000	39,188,400
2013-03-20	2013-03-15	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	X - Other	-100,000	2,762,560	-3.49	10.00	-1,000,000	27,625,600
2013-03-06	2013-03-05	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	P - Purchase	500	64,500	0.78	2.76	1,380	178,020
2013-03-06	2013-03-04	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	P - Purchase	1,000	64,000	1.59	1.94	1,945	124,480
2013-03-06	2013-03-04	4	AEGR	Aegerion Pharmaceuticals, Inc. Call option (right to buy)	P - Purchase	1,000	2,000	100.00	8.26	8,260	16,520
2013-03-06	2013-03-04	4	AEGR	Aegerion Pharmaceuticals, Inc. Call option (right to buy)	P - Purchase	1,000	2,000	100.00	8.26	8,260	16,520
2013-02-27	2013-02-25	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	P - Purchase	500	63,000	0.80	0.90	450	56,700
2013-02-27	2013-02-25	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-500	62,500	-0.79	1.05	-525	65,625
2013-02-21	2013-02-20	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	P - Purchase	500	62,000	0.81	0.78	390	48,360
2013-02-21	2013-02-20	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-500	61,500	-0.81	1.04	-520	63,960
2013-02-21	2013-02-19	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	P - Purchase	1,000	61,000	1.67	0.79	790	48,190
2013-02-21	2013-02-19	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-1,000	60,000	-1.64	0.89	-890	53,400
2013-02-13	2013-02-11	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	P - Purchase	1,000	59,000	1.72	2.08	2,080	122,720
2013-02-13	2013-02-11	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-1,000	58,000	-1.69	0.38	-380	22,040
2013-02-08	2013-02-07	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	P - Purchase	1,500	57,000	2.70	2.33	3,495	132,810
2013-02-08	2013-02-07	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-1,500	55,500	-2.63	0.27	-405	14,985
2013-02-08	2013-02-06	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	P - Purchase	4,000	54,000	8.00	1.65	6,600	89,100
2013-02-08	2013-02-06	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-2,000	50,000	-3.85	0.55	-1,100	27,500
2013-02-06	2013-02-05	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-6,000	48,000	-11.11	0.69	-4,140	33,120
2013-02-06	2013-02-04	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-500	42,000	-1.18	2.05	-1,025	86,100
2013-02-05	2013-02-01	4	AEGR	Aegerion Pharmaceuticals, Inc. Common Stock	P - Purchase	50,000	3,373,426	1.50	27.79	1,389,400	93,740,762
2013-02-04	2013-02-01	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-1,000	41,500	-2.35	0.80	-800	33,200
2013-02-01	2013-01-31	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	P - Purchase	1,000	40,500	2.53	1.45	1,450	58,725
2013-02-01	2013-01-31	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-1,000	39,500	-2.47	0.88	-875	34,562
2013-02-01	2013-01-30	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	P - Purchase	2,000	38,500	5.48	1.32	2,650	51,012
2013-02-01	2013-01-30	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-2,000	36,500	-5.19	1.05	-2,100	38,325
2013-01-30	2013-01-29	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	P - Purchase	4,000	34,500	13.11	1.71	6,840	58,995
2013-01-30	2013-01-29	4	RPRX	REPROS THERAPEUTICS INC. Call option (right to buy)	P - Purchase	500	30,500	1.67	0.05	25	1,525
2013-01-30	2013-01-29	4	RPRX	REPROS THERAPEUTICS INC. Call option (right to buy)	P - Purchase	500	30,000	1.69	0.10	50	3,000
2013-01-30	2013-01-29	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-4,000	29,500	-11.94	0.80	-3,200	23,600
2013-01-30	2013-01-28	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	P - Purchase	2,000	25,500	8.51	1.50	3,000	38,250
2013-01-30	2013-01-28	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	P - Purchase	2,000	23,500	9.30	1.85	3,700	43,475
2013-01-30	2013-01-28	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	P - Purchase	2,000	21,500	10.26	0.65	1,300	13,979
2013-01-30	2013-01-28	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	P - Purchase	1,500	19,500	8.33	2.87	4,300	55,901
2013-01-30	2013-01-28	4	RPRX	REPROS THERAPEUTICS INC. Put option (right to sell)	P - Purchase	1,000	18,000	5.88	0.80	800	14,400
2013-01-30	2013-01-28	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-1,000	17,000	-5.56	1.19	-1,190	20,230
2013-01-30	2013-01-28	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-1,000	16,000	-5.88	2.43	-2,428	38,846
2013-01-30	2013-01-28	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-1,000	15,000	-6.25	0.80	-800	12,000
2013-01-30	2013-01-28	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-2,000	14,000	-12.50	1.47	-2,935	20,545
2013-01-30	2013-01-28	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-2,000	12,000	-14.29	1.00	-2,001	12,004
2013-01-30	2013-01-28	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-2,000	10,000	-16.67	0.88	-1,757	8,787
2013-01-23	2013-01-22	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-500	8,000	-5.88	0.80	-400	6,400
2013-01-23	2013-01-22	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-500	7,500	-6.25	1.40	-702	10,531
2013-01-22	2013-01-18	4	AEGR	Aegerion Pharmaceuticals, Inc. Common Stock	P - Purchase	50,000	3,323,426	1.53	27.62	1,381,000	91,793,026
2013-01-18	2013-01-17	4	AEGR	Aegerion Pharmaceuticals, Inc. Common Stock	P - Purchase	25,000	3,273,426	0.77	26.73	668,142	87,484,601
2013-01-18	2013-01-17	4	AEGR	Aegerion Pharmaceuticals, Inc. Common Stock	P - Purchase	25,000	3,273,426	0.77	26.73	668,142	87,484,601
2013-01-15	2013-01-11	4	AEGR	Aegerion Pharmaceuticals, Inc. Common Stock	P - Purchase	150,000	3,223,426	4.88	26.64	3,996,000	85,872,069
2013-01-15	2013-01-11	4	AEGR	Aegerion Pharmaceuticals, Inc. Common Stock	P - Purchase	200,000	3,073,426	6.96	27.66	5,531,220	84,998,977
2013-01-15	2013-01-11	4	AEGR	Aegerion Pharmaceuticals, Inc. Common Stock	P - Purchase	125,000	2,873,426	4.55	26.64	3,330,000	76,548,069
2013-01-11	2013-01-10	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-2,000	7,000	-22.22	1.89	-3,780	13,230
2013-01-04	2013-01-04	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-1,000	5,000	-16.67	1.20	-1,200	6,000
2013-01-04	2013-01-04	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-1,000	4,000	-20.00	1.91	-1,910	7,640
2013-01-04	2013-01-03	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-2,000	3,000	-40.00	1.35	-2,700	4,050
2013-01-04	2013-01-03	4	RPRX	REPROS THERAPEUTICS INC. Call option (obligation to sell)	S - Sale	-1,000	1,000	-50.00	2.01	-2,010	2,010
2012-12-13		3	ACRX	ACELRX PHARMACEUTICALS INC Common Stock			5,008,400
2012-12-05	2012-12-04	4	AEGR	Aegerion Pharmaceuticals, Inc. Common Stock	P - Purchase	20,000	2,615,293	0.77	21.27	425,400	55,627,282
2012-12-03	2012-11-28	4	AEGR	Aegerion Pharmaceuticals, Inc. COMMON STOCK	P - Purchase	70,000	2,565,293	2.81	21.76	1,523,200	55,820,776
2012-12-03	2012-11-21	4	AEGR	Aegerion Pharmaceuticals, Inc. COMMON STOCK	P - Purchase	20,000	2,495,293	0.81	20.75	415,000	51,777,330
2012-12-03	2012-11-20	4	AEGR	Aegerion Pharmaceuticals, Inc. COMMON STOCK	P - Purchase	20,000	2,475,293	0.81	21.01	420,200	52,005,906
2012-12-03	2012-11-15	4	AEGR	Aegerion Pharmaceuticals, Inc. COMMON STOCK	P - Purchase	10,000	2,455,293	0.41	19.50	195,000	47,878,214
2012-12-03	2012-11-07	4	AEGR	Aegerion Pharmaceuticals, Inc. COMMON STOCK	P - Purchase	30,000	2,445,293	1.24	21.12	633,600	51,644,588
2012-12-03	2012-11-29	4	AEGR	Aegerion Pharmaceuticals, Inc. COMMON STOCK	P - Purchase	30,000	2,595,293	1.17	22.71	681,300	58,939,104
2012-12-03	2012-10-19	4	AEGR	Aegerion Pharmaceuticals, Inc. CALL OPTION (OBLIGATION TO SELL)	X - Other	-2,475	0	-100.00
2012-12-03	2012-10-19	4	AEGR	Aegerion Pharmaceuticals, Inc. COMMON STOCK	X - Other	-247,500	2,347,233	-9.54	17.50	-4,331,250	41,076,578
2012-12-03		3	AEGR	Aegerion Pharmaceuticals, Inc. COMMON STOCK			2,415,293
2012-12-03		3	AEGR	Aegerion Pharmaceuticals, Inc. COMMON STOCK			133,133
2012-12-03		3	AEGR	Aegerion Pharmaceuticals, Inc. COMMON STOCK			2,594,733
2012-12-03		3	AEGR	Aegerion Pharmaceuticals, Inc. COMMON STOCK			133,133
2012-05-15	2012-05-14	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	P - Purchase	59,500	2,862,560	2.12	7.38	439,283	21,133,994
2012-05-14	2012-05-11	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	P - Purchase	25,000	2,803,060	0.90	6.35	158,800	17,805,037
2012-05-14	2012-05-11	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	P - Purchase	145,000	2,778,060	5.51	6.35	921,040	17,646,237
2012-05-11	2012-05-10	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	P - Purchase	15,000	2,633,060	0.57	4.82	72,300	12,691,349
2012-05-11	2012-05-10	4	RPRX	REPROS THERAPEUTICS INC. Common Stock	P - Purchase	310,000	2,618,060	13.43	4.82	1,493,797	12,615,646
2008-12-03	2008-11-19	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	S - Sale	-9,600,000	20,580,260	-31.81	0.15	-1,466,880	3,144,664
2008-12-03	2008-11-18	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	S - Sale	-299,570	0	-100.00	0.15	-45,774
2008-12-03	2008-11-18	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	S - Sale	-400,000	299,570	-57.18	0.15	-61,120	45,774
2008-12-03	2008-11-18	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	S - Sale	-1,943,250	699,570	-73.53	0.14	-273,804	98,569
2008-12-03	2008-11-18	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	S - Sale	-400,000	2,642,820	-13.15	0.16	-64,560	426,551
2008-12-03	2008-11-18	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	S - Sale	-29,740	3,042,820	-0.97	0.16	-4,729	483,808
2008-12-03	2008-11-18	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	S - Sale	-2,696,450	30,180,260	-8.20	0.15	-412,018	4,611,544
2008-12-03	2008-11-18	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	S - Sale	-24,681,360	32,876,710	-42.88	0.14	-3,477,604	4,632,328
2008-06-19	2008-06-10	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	2,040	3,072,560	0.07	3.23	6,589	9,924,369
2008-06-19	2008-06-10	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	48,960	57,558,070	0.09	3.23	158,141	185,912,566
2008-06-11	2008-06-09	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	1,340	3,070,520	0.04	3.36	4,502	10,316,947
2008-06-11	2008-06-09	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	32,260	57,509,110	0.06	3.36	108,394	193,230,610
2008-06-11	2008-06-06	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	4,000	3,069,180	0.13	3.43	13,720	10,527,287
2008-06-11	2008-06-06	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	96,000	57,476,850	0.17	3.43	329,280	197,145,596
2008-06-11	2008-06-05	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	8,000	3,065,180	0.26	3.15	25,200	9,655,317
2008-06-11	2008-06-05	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	4,000	3,057,180	0.13	3.37	13,480	10,302,697
2008-06-11	2008-06-05	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	192,000	57,380,850	0.34	3.15	604,800	180,749,678
2008-06-11	2008-06-05	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinarry Shares	P - Purchase	96,000	57,188,850	0.17	3.37	323,520	192,726,424
2008-05-06	2008-05-02	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	2,000	3,036,140	0.07	3.88	7,760	11,780,223
2008-05-06	2008-05-02	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	48,000	56,683,890	0.08	3.88	186,240	219,933,493
2008-05-06	2008-05-01	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	4,200	3,034,140	0.14	3.75	15,750	11,378,025
2008-05-06	2008-05-01	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	100,800	56,635,890	0.18	3.75	378,000	212,384,588
2008-04-16	2008-04-10	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	10,000	3,015,650	0.33	3.56	35,579	10,729,381
2008-04-16	2008-04-10	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	90,000	56,191,770	0.16	3.58	322,011	201,048,534
2008-03-20	2008-03-18	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	6,650	2,984,350	0.22	3.12	20,749	9,311,769
2008-03-20	2008-03-18	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	156,350	55,797,070	0.28	3.12	487,843	174,098,018
2008-03-20	2008-03-14	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	12,000	2,977,700	0.40	3.32	39,856	9,889,835
2008-03-20	2008-03-14	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	15,780	2,965,700	0.53	3.33	52,566	9,879,340
2008-03-20	2008-03-14	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary shares	P - Purchase	188,000	55,640,720	0.34	3.32	624,404	184,799,523
2008-03-20	2008-03-14	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary shares	P - Purchase	247,220	55,452,720	0.45	3.33	823,539	184,724,101
2008-03-20	2008-03-13	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	6,000	2,949,920	0.20	3.37	20,240	9,950,965
2008-03-20	2008-03-13	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	8,820	2,943,920	0.30	3.38	29,814	9,951,333
2008-03-20	2008-03-12	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	9,000	2,935,100	0.31	3.37	30,295	9,879,840
2008-03-20	2008-03-12	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary shares	P - Purchase	17,400	2,926,100	0.60	3.35	58,292	9,802,728
2008-03-19	2008-03-13	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	94,000	55,205,500	0.17	3.37	317,090	186,224,713
2008-03-19	2008-03-13	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	138,180	55,111,500	0.25	3.38	467,090	186,293,403
2008-03-19	2008-03-12	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	272,600	54,973,320	0.50	3.35	913,237	184,166,119
2008-03-19	2008-03-12	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	141,000	54,700,720	0.26	3.37	474,620	184,128,094
2008-03-19	2008-03-11	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	11,900	2,908,700	0.41	3.30	39,327	9,612,672
2008-03-19	2008-03-11	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	30,000	2,896,800	1.05	3.31	99,351	9,593,333
2008-03-19	2008-03-11	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	107,100	54,559,720	0.20	3.30	353,944	180,308,963
2008-03-19	2008-03-11	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	470,000	54,452,620	0.87	3.31	1,556,499	180,330,742
2008-03-19	2008-03-10	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	25,200	2,866,800	0.89	3.28	82,568	9,393,070
2008-03-19	2008-03-10	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	30,000	2,841,600	1.07	3.15	94,500	8,951,040
2008-03-19	2008-03-10	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	30,000	2,811,600	1.08	3.25	97,368	9,125,329
2008-03-19	2008-03-10	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	394,800	5,398,260	7.89	3.28	1,293,562	17,687,399
2008-03-19	2008-03-10	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	470,000	53,587,820	0.88	3.15	1,480,500	168,801,633
2008-03-19	2008-03-10	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	470,000	53,117,820	0.89	3.25	1,525,432	172,399,197
2008-03-19	2008-03-07	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	60,000	2,781,600	2.20	3.74	224,268	10,397,064
2008-03-19	2008-03-07	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	9,020	2,721,600	0.33	3.65	32,893	9,924,859
2008-03-19	2008-03-07	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	141,440	52,647,820	0.27	3.65	515,789	191,990,805
2008-03-19	2008-03-07	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	940,000	52,506,380	1.82	3.74	3,513,532	196,258,347
2008-03-19	2008-03-06	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	39,300	2,712,580	1.47	3.86	151,824	10,479,239
2008-03-19	2008-03-06	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	15,600	2,673,280	0.59	3.73	58,146	9,964,117
2008-03-19	2008-03-06	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	244,400	51,566,380	0.48	3.73	910,952	192,203,368
2008-03-19	2008-03-06	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	615,700	51,321,980	1.21	3.86	2,378,572	198,267,073
2008-03-10	2008-03-05	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	34,200	2,657,680	1.30	3.94	134,700	10,467,538
2008-03-10	2008-03-05	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	535,800	50,706,280	1.07	3.94	2,110,302	199,711,754
2008-03-10	2008-03-04	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	6,640	2,623,480	0.25	3.99	26,490	10,466,111
2008-03-10	2008-03-04	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	18,000	2,616,840	0.69	3.98	71,656	10,417,378
2008-03-10	2008-03-04	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	282,000	50,170,480	0.57	3.98	1,122,614	199,723,664
2008-03-10	2008-03-04	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	104,060	49,888,480	0.21	3.99	415,137	199,025,102
2008-02-29	2008-02-27	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	6,600	2,598,840	0.25	4.01	26,484	10,428,365
2008-02-29	2008-02-27	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	103,400	49,784,420	0.21	4.01	414,913	199,769,942
2008-02-28	2008-02-26	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	3,790	2,592,240	0.15	3.95	14,970	10,239,348
2008-02-28	2008-02-26	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	24,000	2,588,450	0.94	3.91	93,742	10,110,227
2008-02-28	2008-02-26	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	59,390	49,681,020	0.12	3.95	234,590	196,240,029
2008-02-28	2008-02-26	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	376,000	49,621,630	0.76	3.91	1,468,618	193,817,125
2008-02-28	2008-02-25	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	46,500	2,564,450	1.85	3.87	179,871	9,919,805
2008-02-28	2008-02-25	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	6,000	2,517,950	0.24	3.86	23,159	9,718,783
2008-02-28	2008-02-25	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	94,000	49,245,630	0.19	3.86	362,821	190,078,283
2008-02-28	2008-02-25	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	728,500	49,151,630	1.50	3.87	2,817,984	190,128,335
2008-02-28	2008-02-22	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	12,000	2,511,950	0.48	3.95	47,431	9,928,734
2008-02-28	2008-02-22	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	30,000	2,499,950	1.21	3.95	118,374	9,864,303
2008-02-28	2008-02-22	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	28,380	2,469,950	1.16	3.95	112,101	9,756,302
2008-02-28	2008-02-22	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	188,000	48,432,130	0.39	3.95	743,089	191,432,837
2008-02-28	2008-02-22	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	470,000	48,235,130	0.98	3.95	1,854,526	190,326,176
2008-02-28	2008-02-22	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	444,620	47,765,130	0.94	3.95	1,756,249	188,672,264
2008-02-22	2008-02-20	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	100	2,441,570	0.00	3.84	384	9,375,629
2008-02-22	2008-02-20	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	900	47,320,510	0.00	3.84	3,456	181,710,758
2008-02-19	2008-02-13	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	360	2,441,470	0.01	3.81	1,371	9,297,606
2008-02-19	2008-02-13	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	5,640	473,196,910	0.00	3.81	21,478	1,802,028,473
2008-02-08	2008-02-07	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary shares	P - Purchase	600	3,441,110	0.02	3.40	2,038	11,686,010
2008-02-08	2008-02-07	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary shares	P - Purchase	9,400	47,313,970	0.02	3.40	31,922	160,678,242
2008-02-08	2008-02-06	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	21,000	2,440,510	0.87	3.71	77,914	9,054,780
2008-02-08	2008-02-06	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	120	2,419,510	0.00	3.68	442	8,903,797
2008-02-08	2008-02-06	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	329,000	47,304,570	0.70	3.71	1,220,656	175,509,416
2008-02-08	2008-02-06	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary shares	P - Purchase	1,880	46,975,570	0.00	3.68	6,918	172,870,098
2008-02-06	2008-02-05	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary shares	P - Purchase	9,060	2,419,390	0.38	3.79	34,314	9,163,198
2008-02-06	2008-02-05	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary shares	P - Purchase	6,060	2,410,330	0.25	3.75	22,725	9,038,738
2008-02-06	2008-02-05	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary shares	P - Purchase	141,940	46,973,690	0.30	3.79	537,584	177,908,154
2008-02-06	2008-02-05	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary shares	P - Purchase	94,940	46,831,750	0.20	3.75	356,025	175,619,062
2008-02-06	2008-02-04	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary shares	P - Purchase	8,400	2,404,270	0.35	3.87	32,495	9,300,678
2008-02-06	2008-02-04	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary shares	P - Purchase	33,000	2,320,270	1.44	3.88	128,056	9,003,808
2008-02-06	2008-02-04	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary shares	P - Purchase	131,600	46,736,810	0.28	3.87	509,081	180,796,676
2008-02-06	2008-02-04	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary shares	P - Purchase	517,000	46,605,210	1.12	3.88	2,006,218	180,851,517
2008-02-05	2008-02-01	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	42,000	2,322,870	1.84	3.69	155,022	8,573,713
2008-02-05	2008-02-01	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	658,000	46,088,210	1.45	3.69	2,428,678	170,111,583
2008-02-05	2008-01-31	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	30,000	2,320,870	1.31	3.43	102,987	7,967,315
2008-02-05	2008-01-31	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	23,640	2,290,870	1.04	3.50	82,723	8,016,441
2008-02-05	2008-01-31	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	470,000	45,430,210	1.05	3.43	1,613,463	155,957,368
2008-02-05	2008-01-31	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	370,360	44,960,210	0.83	3.50	1,296,001	157,329,263
2008-02-01	2008-01-30	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	15,000	2,267,230	0.67	3.23	48,456	7,324,060
2008-02-01	2008-01-30	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	235,000	44,589,850	0.53	3.23	759,144	144,043,051
2008-01-30	2008-01-29	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	6,000	2,252,230	0.27	3.23	19,379	7,274,252
2008-01-30	2008-01-29	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	94,000	44,354,850	0.21	3.23	303,601	143,257,295
2008-01-30	2008-01-28	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	600	2,246,230	0.03	3.23	1,938	7,255,323
2008-01-30	2008-01-28	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	40,200	2,245,630	1.82	3.21	129,203	7,217,455
2008-01-30	2008-01-28	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	9,400	44,260,850	0.02	3.23	30,362	142,962,546
2008-01-30	2008-01-28	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	629,800	44,251,450	1.44	3.21	2,024,177	142,224,160
2008-01-29	2008-01-25	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	12,000	2,205,430	0.55	3.24	38,856	7,141,182
2008-01-29	2008-01-25	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	188,000	43,621,650	0.43	3.24	608,744	141,246,903
2008-01-28	2008-01-24	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	42,300	2,193,430	1.97	2.99	126,477	6,558,356
2008-01-28	2008-01-24	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	13,800	2,151,130	0.65	2.98	41,124	6,410,367
2008-01-28	2008-01-24	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	66,270	43,433,650	0.15	2.99	198,147	129,866,614
2008-01-28	2008-01-24	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	216,200	42,770,950	0.51	2.98	644,276	127,457,431
2008-01-28	2008-01-23	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	18,000	2,137,330	0.85	2.88	51,908	6,163,632
2008-01-28	2008-01-23	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	282,000	42,554,750	0.67	2.88	813,232	122,719,388
2008-01-25	2008-01-22	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	790	2,119,330	0.04	2.90	2,293	6,151,355
2008-01-25	2008-01-22	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	12,520	42,272,750	0.03	2.90	36,339	122,696,657
2008-01-25	2008-01-18	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	7,560	2,118,540	0.36	3.16	23,888	6,694,163
2008-01-25	2008-01-18	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	11,820	2,110,980	0.56	3.13	36,994	6,606,945
2008-01-25	2008-01-18	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	118,440	42,260,230	0.28	3.16	374,247	133,533,875
2008-01-25	2008-01-18	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	185,180	42,141,790	0.44	3.13	579,576	131,895,374
2008-01-25	2008-01-17	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	11,460	2,099,160	0.55	3.01	34,444	6,309,235
2008-01-25	2008-01-17	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	9,240	2,087,700	0.44	3.06	28,240	6,380,638
2008-01-25	2008-01-17	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	144,760	41,956,610	0.35	3.06	442,430	128,231,987
2008-01-25	2008-01-17	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	179,540	41,811,850	0.43	3.01	539,625	125,669,696
2008-01-25	2008-01-16	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	27,600	2,078,460	1.35	3.06	84,346	6,351,774
2008-01-25	2008-01-16	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	180	2,008,860	0.01	3.16	568	6,341,368
2008-01-25	2008-01-16	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	432,400	41,632,310	1.05	3.10	1,340,440	129,060,161
2008-01-25	2008-01-16	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	2,820	41,199,910	0.01	3.16	8,902	130,055,756
2008-01-25	2008-01-15	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	42,000	2,050,680	2.09	3.11	130,712	6,382,126
2008-01-25	2008-01-15	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	15,000	2,008,680	0.75	3.06	45,909	6,147,766
2008-01-25	2008-01-15	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	658,000	41,197,090	1.62	3.11	2,047,828	128,213,583
2008-01-25	2008-01-15	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	235,000	40,539,090	0.58	3.06	719,241	124,073,939
2008-01-18	2008-01-16	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	27,600	2,078,460	1.35	3.10	85,560	6,443,226
2008-01-18	2008-01-16	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	180	2,050,860	0.01	3.16	568	6,473,950
2008-01-18	2008-01-16	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	432,400	41,632,310	1.05	3.10	1,340,440	129,060,161
2008-01-18	2008-01-16	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	2,820	41,199,910	0.01	3.16	8,902	130,055,756
2008-01-18	2008-01-15	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	42,000	2,050,680	2.09	3.11	130,712	6,382,126
2008-01-18	2008-01-15	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	15,000	2,008,680	0.75	3.06	45,909	6,147,766
2008-01-18	2008-01-15	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	658,000	41,197,090	1.62	3.11	2,047,828	128,213,583
2008-01-18	2008-01-15	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	235,000	40,539,000	0.58	3.06	719,241	124,073,663
2008-01-15	2008-01-14	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	22,200	1,993,680	1.13	3.41	75,724	6,800,442
2008-01-15	2008-01-14	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	347,800	40,304,090	0.87	3.41	1,186,346	137,477,251
2008-01-15	2008-01-11	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	28,320	1,971,480	1.46	3.39	96,076	6,688,246
2008-01-15	2008-01-11	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	443,680	39,956,290	1.12	3.39	1,505,184	135,551,714
2008-01-11	2008-01-10	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	69,000	1,943,160	3.68	3.30	227,748	6,413,788
2008-01-11	2008-01-10	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	1,081,000	39,521,610	2.81	3.30	3,568,057	130,448,978
2008-01-11	2008-01-09	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	36,000	1,874,160	1.96	3.27	117,896	6,137,687
2008-01-11	2008-01-09	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	24,060	1,838,160	1.33	3.30	79,283	6,057,105
2008-01-11	2008-01-09	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	564,000	37,431,610	1.53	3.27	1,847,044	122,584,780
2008-01-11	2008-01-09	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	376,940	37,867,610	1.01	3.30	1,242,093	124,781,348
2008-01-11	2008-01-08	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	30,000	1,814,100	1.68	3.26	97,743	5,910,519
2008-01-11	2008-01-07	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	20,000	1,784,100	1.13	2.87	57,372	5,117,869
2008-01-11	2008-01-07	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	81,600	1,764,100	4.85	3.11	253,401	5,478,236
2008-01-11	2008-01-07	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	6,000	1,682,500	0.36	3.10	18,600	5,215,750
2008-01-11	2008-01-07	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	1,278,400	37,020,670	3.58	3.11	3,969,943	114,963,989
2008-01-11	2008-01-07	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	94,000	35,742,270	0.26	3.10	291,400	110,801,037
2008-01-11	2008-01-07	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	180,000	35,648,270	0.51	2.87	516,348	102,260,627
2008-01-11	2007-01-08	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	470,000	37,490,670	1.27	3.26	1,531,307	122,148,352
2008-01-04	2008-01-02	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	1,222,000	35,045,270	3.61	2.89	3,531,580	101,280,830
2008-01-04	2007-01-02	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	78,000	1,649,500	4.96	2.89	225,420	4,767,055
2008-01-02	2007-12-31	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	69,000	1,571,500	4.59	2.74	188,750	4,298,838
2008-01-02	2007-12-31	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	1,081,000	33,823,270	3.30	2.74	2,957,076	92,523,555
2008-01-02	2007-12-28	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	48,000	1,502,500	3.30	2.69	129,226	4,045,030
2008-01-02	2007-12-28	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	752,000	32,742,270	2.35	2.69	2,024,534	88,148,739
2007-12-31	2007-12-27	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	18,000	1,454,500	1.25	2.60	46,717	3,775,009
2007-12-31	2007-12-27	4	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares	P - Purchase	282,000	31,990,270	0.89	2.60	731,903	83,027,547
2007-12-31		3/A	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares			31,708,270
2007-12-07		3	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares			27,876,060
2007-12-07		3	XTLB	XTL BIOPHARMACEUTICALS LTD Ordinary Shares			1,436,500
2004-12-06	2004-12-03	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	S - Sale	-1,315,000	209,100	-86.28	4.72	-6,200,225	985,906
2004-12-06	2004-12-03	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	S - Sale	-50,000	1,524,100	-3.18	4.55	-227,500	6,934,655
2004-12-06	2004-12-03	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	S - Sale	-30,000	1,574,100	-1.87	4.35	-130,500	6,847,335
2004-12-06	2004-12-02	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	S - Sale	-273,550	1,604,100	-14.57	4.47	-1,222,221	7,167,119
2004-12-06	2004-12-02	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	2,000	1,877,650	0.11	3.98	7,960	7,473,047
2004-12-06	2004-12-02	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	S - Sale	-2,000	1,875,650	-0.11	4.47	-8,936	8,380,404
2004-12-06	2004-12-02	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	S - Sale	-25,000	1,877,650	-1.31	4.90	-122,500	9,200,485
2004-12-06	2004-12-02	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	S - Sale	-70,900	1,902,650	-3.59	4.47	-316,781	8,501,040
2004-12-06	2004-12-02	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	S - Sale	-28,550	0	-100.00	4.47	-127,561
2004-10-12	2004-10-08	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	14,900	1,973,550	0.76	9.87	146,991	19,469,465
2004-10-12	2004-10-08	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	1,000	27,950	3.71	9.87	9,865	275,732
2004-10-08	2004-10-07	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	9,000	1,958,650	0.46	10.11	90,964	19,796,271
2004-10-08	2004-10-07	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	1,000	26,950	3.85	10.11	10,107	272,386
2004-10-08	2004-10-06	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	9,000	1,949,650	0.46	9.90	89,112	19,304,070
2004-10-08	2004-10-06	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	1,000	25,950	4.01	9.90	9,901	256,939
2004-10-06	2004-10-05	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	15,800	1,940,650	0.82	9.90	156,417	19,212,047
2004-10-06	2004-10-05	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	1,700	24,950	7.31	9.90	16,830	247,000
2004-10-06	2004-10-04	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	13,100	1,924,850	0.69	9.72	127,341	18,710,889
2004-10-06	2004-10-04	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	1,400	23,250	6.41	9.72	13,609	226,006
2004-10-04	2004-10-01	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	19,400	1,911,750	1.03	9.59	186,046	18,333,682
2004-10-04	2004-10-01	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	2,100	21,850	10.63	9.59	20,139	209,542
2004-10-04	2004-09-30	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	9,000	1,892,350	0.48	8.96	80,680	16,963,972
2004-10-04	2004-09-30	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	1,000	19,750	5.33	8.96	8,964	177,049
2004-09-16	2004-09-14	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	22,100	1,883,350	1.19	7.69	169,843	14,473,921
2004-09-16	2004-09-14	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	2,400	18,750	14.68	7.69	18,444	144,098
2004-09-15	2004-09-13	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	23,400	1,861,250	1.27	7.17	167,734	13,341,626
2004-09-15	2004-09-13	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	2,500	16,350	18.05	7.17	17,920	117,198
2004-09-13	2004-09-09	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	4,300	1,837,850	0.23	6.85	29,455	12,589,272
2004-09-13	2004-09-09	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	400	13,850	2.97	6.85	2,740	94,872
2004-09-01	2004-08-31	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	9,000	1,833,550	0.49	6.84	61,563	12,542,032
2004-09-01	2004-08-30	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	9,000	1,824,550	0.50	6.84	61,537	12,475,178
2004-09-01	2004-08-30	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	1,000	13,450	8.03	6.84	6,837	91,963
2004-08-20	2004-08-19	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	700	12,450	5.96	5.84	4,091	72,765
2004-08-20	2004-08-19	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	6,200	1,815,550	0.34	5.84	36,237	10,611,164
2004-08-20	2004-08-18	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	4,500	11,750	62.07	5.83	26,214	68,447
2004-08-20	2004-08-18	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	40,500	1,809,350	2.29	5.83	235,925	10,540,007
2004-08-19	2004-08-16	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	S - Sale	-200	7,250	-2.68	5.50	-1,100	39,875
2004-08-19	2004-08-16	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	200	7,450	2.76	5.10	1,020	37,995
2004-08-16	2004-08-12	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	2,500	1,768,850	0.14	4.75	11,875	8,402,038
2004-08-13	2004-08-11	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	2,300	7,250	46.46	4.72	10,850	34,202
2004-08-13	2004-08-11	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	21,300	1,766,350	1.22	4.72	100,483	8,332,756
2004-07-21	2004-07-19	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	2,800	4,950	130.23	5.67	15,889	28,090
2004-07-21	2004-07-19	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	25,652	1,745,050	1.49	5.67	145,567	9,902,635
2004-07-19	2004-07-16	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	1,400	2,150	186.67	5.89	8,242	12,657
2004-07-19	2004-07-16	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	12,648	1,719,398	0.74	5.89	74,468	10,123,300
2004-07-19	2004-07-15	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	750	750		5.96	4,472	4,472
2004-07-19	2004-07-15	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	6,750	1,706,750	0.40	5.96	40,252	10,177,862
2004-05-18	2004-05-14	4/A	BPA	BIOSANTE PHARMACEUTICALS INC Warrants	P - Purchase	97,500	97,500
2004-05-18	2004-05-14	4/A	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	650,000	1,700,000	61.90	6.00	3,900,000	10,200,000
2004-05-12	2004-05-11	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	P - Purchase	650,000	1,700,000	61.90	6.00	3,900,000	10,200,000
2004-02-12		3	ANTR.OB	ANTARES PHARMA INC Common Stock, $0.01 par value per share			2,700,000
2004-02-05	2004-02-03	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	S - Sale	-87,400	1,050,000	-7.68	6.44	-562,576	6,758,640
2004-01-23	2004-01-23	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	S - Sale	-35,000	1,137,400	-2.99	5.62	-196,700	6,392,188
2004-01-23	2004-01-22	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	S - Sale	-100,000	1,172,400	-7.86	5.68	-568,000	6,659,232
2004-01-23	2004-01-21	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	S - Sale	-5,000	1,272,400	-0.39	5.65	-28,250	7,189,060
2004-01-23	2004-01-21	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	S - Sale	-15,000	1,277,400	-1.16	5.84	-87,600	7,460,016
2004-01-23	2004-01-21	4	BPA	BIOSANTE PHARMACEUTICALS INC Common Stock	S - Sale	-100,000	1,292,400	-7.18	5.66	-566,000	7,314,984
2003-08-13		3	BISP.OB	BIOSANTE PHARMACEUTICALS INC Common Stock, par value $0.0001			225,000
2003-08-13		3	BISP.OB	BIOSANTE PHARMACEUTICALS INC Common Stock, par value $0.0001			1,392,400

गैर-डेरिवेटिव या डेरिवेटिव प्रतिभूति की खुला बाज़ार या निजी खरीद

गैर-डेरिवेटिव या डेरिवेटिव प्रतिभूति का खुला बाज़ार या निजी बिक्री

कंपनी से प्रतिभूतियों का अनुदान, पुरस्कार या अन्य अधिग्रहण (जैसे एक ऑप्शन)

डेरिवेटिव का रूपांतरण

कंपनी को प्रतिभूतियों की बिक्री या हस्तांतरण

कंपनी से प्राप्त प्रतिभूतियों के हिस्से का उपयोग करके एक्सरसाइज मूल्य या कर दायित्व का भुगतान

इनसाइडर द्वारा या उसे प्रतिभूतियों का उपहार

इक्विटी स्वैप और समान हेजिंग लेनदेन

कंपनी से प्राप्त डेरिवेटिव प्रतिभूति के एक्सरसाइज या रूपांतरण (जैसे कि एक ऑप्शन)

किसी लेन-देन को स्वेच्छा से फॉर्म 4 पर रिपोर्ट किया गया

अन्य (लेन-देन का वर्णन करने वाले फ़ुटनोट के साथ)